<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">59850</article-id><article-id pub-id-type="doi">10.7554/eLife.59850</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Genetic timestamping of plasma cells in vivo reveals tissue-specific homeostatic population turnover</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-192993"><name><surname>Xu</surname><given-names>An Qi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8008-6462</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-192994"><name><surname>Barbosa</surname><given-names>Rita R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-129030"><name><surname>Calado</surname><given-names>Dinis Pedro</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8239-7184</contrib-id><email>dinis.calado@crick.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Immunity and Cancer, The Francis Crick Institute</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution>Peter Gorer Department of Immunobiology, School of Immunology &amp; Microbial Sciences, King’s College London</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Sen</surname><given-names>Ranjan</given-names></name><role>Reviewing Editor</role><aff><institution>National Institute on Aging</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Senior Editor</role><aff><institution>Indian Institute of Science Education and Research (IISER)</institution><country>India</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>02</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e59850</elocation-id><history><date date-type="received" iso-8601-date="2020-06-10"><day>10</day><month>06</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-11-01"><day>01</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Xu et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Xu et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-59850-v2.pdf"/><abstract><p>Plasma cells (PCs) are essential for protection from infection, and at the origin of incurable cancers. Current studies do not circumvent the limitations of removing PCs from their microenvironment and confound formation and maintenance. Also, the investigation of PC population dynamics has mostly relied on nucleotide analog incorporation that does not label quiescent cells, a property of most PCs. The main impediment is the lack of tools to perform specific genetic manipulation in vivo. Here we characterize a genetic tool (Jchain<sup>creERT2</sup>) in the mouse that permits first-ever specific genetic manipulation in PCs in vivo, across immunoglobulin isotypes. Using this tool, we found that splenic and bone marrow PC numbers remained constant over-time with the decay in genetically labeled PCs being compensated by unlabeled PCs, supporting homeostatic population turnover in these tissues. The Jchain<sup>creERT2</sup> tool paves the way for an in-depth mechanistic understanding of PC biology and pathology in vivo, in their microenvironment.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Jchain</kwd><kwd>Blimp1</kwd><kwd>plasma cells</kwd><kwd>B cells</kwd><kwd>homeostasis</kwd><kwd>cre-loxP</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>FC001057</award-id><principal-award-recipient><name><surname>Calado</surname><given-names>Dinis Pedro</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>FC001057</award-id><principal-award-recipient><name><surname>Calado</surname><given-names>Dinis Pedro</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>FC001057</award-id><principal-award-recipient><name><surname>Calado</surname><given-names>Dinis Pedro</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>[C355/A26819]</award-id><principal-award-recipient><name><surname>Calado</surname><given-names>Dinis Pedro</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>FC AECC</institution></institution-wrap></funding-source><award-id>[C355/A26819]</award-id><principal-award-recipient><name><surname>Calado</surname><given-names>Dinis Pedro</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005010</institution-id><institution>AIRC</institution></institution-wrap></funding-source><award-id>[C355/A26819]</award-id><principal-award-recipient><name><surname>Calado</surname><given-names>Dinis Pedro</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/J008060/1</award-id><principal-award-recipient><name><surname>Calado</surname><given-names>Dinis Pedro</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A new system to genetically label and manipulate plasma cells in vivo in their microenvironment resolves current technical limitations and reveals tissue-specific homeostatic population turnover.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Antibodies produced by plasma cells (PCs) are crucial for immune protection against infection and for vaccination success (<xref ref-type="bibr" rid="bib45">Nutt et al., 2015</xref>). Upon activation, B cells terminally differentiate into PCs, a process initiated by the downregulation of the B cell transcription factor PAX5 (<xref ref-type="bibr" rid="bib26">Kallies et al., 2007</xref>). This event allows the expression of multiple factors normally repressed by PAX5, including <italic>Xbp1</italic> and <italic>Jchain</italic> (<xref ref-type="bibr" rid="bib10">Castro and Flajnik, 2014</xref>; <xref ref-type="bibr" rid="bib45">Nutt et al., 2015</xref>; <xref ref-type="bibr" rid="bib52">Rinkenberger et al., 1996</xref>; <xref ref-type="bibr" rid="bib56">Shaffer et al., 2004</xref>). PAX5 downregulation is also followed by the expression of the transcription factors IRF4 and BLIMP1 that play essential roles in the establishment of the PC program (<xref ref-type="bibr" rid="bib26">Kallies et al., 2007</xref>; <xref ref-type="bibr" rid="bib28">Klein et al., 2006</xref>; <xref ref-type="bibr" rid="bib55">Sciammas et al., 2006</xref>; <xref ref-type="bibr" rid="bib58">Shapiro-Shelef et al., 2003</xref>). Beyond physiology, multiple cancers have a PC as cell of origin, including multiple myeloma, the second most frequent hematological malignancy overall, and for which a cure remains to be found (<xref ref-type="bibr" rid="bib48">Palumbo and Anderson, 2011</xref>). As a consequence, the study of gene function in PC biology and pathology is a subject of intense investigation.</p><p>However, at least in part because of technical limitations most PC studies make use of in vitro and cell transfer systems that remove PCs from their microenvironment. Currently, genetic manipulation of PCs is not specific and targets other cell populations such as B cells, confounding PC formation, and maintenance. Also, studies on the turnover of the PC population are lacking, as investigation of the regulation of PC maintenance has mostly relied on the use of nucleotide analogs that do not track the vast majority of PCs due to their quiescent nature.</p><p>We found amongst well-known PC-associated genes, that <italic>Jchain</italic> (<italic>Igj</italic>) had the highest level and most specific expression in PC populations. JCHAIN is a small polypeptide required to multimerize IgM and IgA, and necessary for the transport of these Ig classes across the mucosal epithelium in a poly-Ig receptor-mediated process (<xref ref-type="bibr" rid="bib7">Brandtzaeg and Prydz, 1984</xref>; <xref ref-type="bibr" rid="bib10">Castro and Flajnik, 2014</xref>; <xref ref-type="bibr" rid="bib41">Max and Korsmeyer, 1985</xref>). Here we characterized in detail a GFP-tagged creERT2 allele at the <italic>Jchain</italic> endogenous locus: <italic>Igj</italic><sup>creERT2</sup>, hereafter termed <italic>Jchain</italic><sup>creERT2</sup>. We found at the single cell level that GFP as a reporter of <italic>Jchain</italic> expression occurred in PCs across immunoglobulin isotypes, including IgG1. Using the <italic>Jchain</italic><sup>creERT2</sup> allele we performed the first-ever highly specific cre-loxP genetic manipulation in PCs residing in their natural microenvironment in vivo. This system allowed inclusive genetic timestamping of PCs, independently of their cell cycle status. We uncovered that the number of PCs in the spleen and bone marrow remained constant over-time with the decay in numbers of genetically labeled PCs being compensated by that of unlabeled PCs, supporting homeostatic population turnover in these tissues. The <italic>Jchain</italic><sup>creERT2</sup> is thus a validated PC specific genetic tool that paves the way for an in-depth mechanistic understanding of PC biology and pathology in vivo, in their microenvironment.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>Jchain</italic> transcripts are highly enriched in plasma cells</title><p>B-to-PC differentiation is a process that involves a complex network of factors (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib45">Nutt et al., 2015</xref>). We investigated the level and specificity of the expression of genes associated with PCs (<italic>Xbp1</italic>, <italic>Jchain</italic>, <italic>Scd1</italic>, <italic>Irf4</italic>, and <italic>Prdm1</italic>) through the analysis of a publicly available RNA sequencing dataset for immune cell populations (ImmGen, [<xref ref-type="bibr" rid="bib20">Heng et al., 2008</xref>]). We first determined the cell populations with the highest transcript level for each factor. <italic>Xbp1</italic> and <italic>Irf4</italic> were primarily expressed in PCs, however, the expression in bone marrow PCs (B_PC_BM) was less than two-fold greater than that of non-PC populations (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The expression of <italic>Sdc1</italic> and <italic>Prdm1</italic> was not specific to PCs (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Notably, peritoneal cavity macrophages (MF_226+II+480lo_PC) expressed more <italic>Sdc1</italic> than bone marrow PCs (B_PC_BM), and a subset of FOXP3<sup>+</sup> T cells (Treg_4_FP3+_Nrplo_Co) expressed higher levels of <italic>Prdm1</italic> than that observed in splenic plasmablasts (B_PB_Sp) and bone marrow PCs (B_PC_BM; <xref ref-type="fig" rid="fig1">Figure 1C</xref>). By contrast, <italic>Jchain</italic> had the highest level of transcript expression in PCs compared to non-PCs and was the most PC specific amongst all factors, with a forty-fold enrichment over germinal center (GC) B cells (B_GC_CB_Sp; <xref ref-type="fig" rid="fig1">Figure 1D</xref>). We concluded that the <italic>Jchain</italic> locus was a suitable candidate for the generation of PC specific genetic tools.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>Jchain</italic> transcripts are highly enriched in plasma cells.</title><p>(<bold>A</bold>) Schematic of the network of factors associated with plasma cell differentiation. Upward arrows indicate increased expression compared to the precursor population. (<bold>B–D</bold>) Differential gene expression analysis using RNA sequencing data (ImmGen, <xref ref-type="bibr" rid="bib20">Heng et al., 2008</xref>). (<bold>B</bold>) Analysis of <italic>Xbp1</italic> and <italic>Irf4</italic>, which encode for XBP1 and IRF4, respectively. (<bold>C</bold>) Analysis of <italic>Sdc1</italic> and <italic>Prdm1</italic>, which encode for CD138 and BLIMP1, respectively. (<bold>D</bold>) Analysis for <italic>Jchain</italic> (<italic>Igj</italic>) that encodes for JCHAIN. ‘x’ indicates fold change. Expression Value Normalized by DESeq2. <ext-link ext-link-type="uri" xlink:href="http://rstats.immgen.org/Skyline/skyline.html">http://rstats.immgen.org/Skyline/skyline.html</ext-link>.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Gene expression values normalised by DESeq2.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59850-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59850-fig1-v2.tif"/></fig></sec><sec id="s2-2"><title><italic>Jchain</italic> is expressed in a small fraction of GC B cells and in most plasma cells</title><p>We searched alleles produced by the EUCOMMTools consortium (<xref ref-type="bibr" rid="bib29">Koscielny et al., 2014</xref>) and identified a genetically engineered <italic>Jchain</italic> allele produced by the Wellcome Trust Sanger Institute: MGI:5633773, hereafter termed <italic>Jchain</italic><sup>creERT2</sup>. The genetically engineered <italic>Jchain</italic> allele contained an <italic>FRT</italic> site between exons 1 and 2 followed by an engrailed two splice acceptor sequence and an <italic>EGFP.2A.cre<sup>ERT2</sup></italic> expression cassette (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). In this design, the expression of the EGFP (GFP) and of cre<sup>ERT2</sup> is linked by a self-cleaving 2A peptide under the transcriptional control of the <italic>Jchain</italic> promoter (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). To determine cells with GFP expression, we initially analyzed the spleen from mice heterozygous for the <italic>Jchain</italic><sup>creERT2</sup> allele that had been immunized with sheep red blood cells (SRBC) 12 days earlier (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). B220 is expressed on the surface of B cells and downregulated during PC differentiation (<xref ref-type="bibr" rid="bib50">Pracht et al., 2017</xref>). We, therefore, defined three cell populations based on the levels of GFP fluorescence and B220 surface expression: GFP<sup>low</sup>B220<sup>high</sup>, GFP<sup>int</sup>B220<sup>int</sup>, GFP<sup>high</sup>B220<sup>low</sup>, and a population negative for both markers (GFP<sup>neg</sup>B220<sup>neg</sup>; <xref ref-type="fig" rid="fig2">Figure 2C</xref>). Next, we determined the fraction of cells within these populations that expressed surface CD138, a commonly used marker to define PCs by flow-cytometry (<xref ref-type="bibr" rid="bib50">Pracht et al., 2017</xref>). The GFP<sup>neg</sup>B220<sup>neg</sup> population did not contain CD138<sup>+</sup> cells, however, the fraction of CD138<sup>+</sup> cells increased in the remaining populations in agreement with the reduction of B220 expression during PC differentiation, and the GFP<sup>int</sup>B220<sup>int</sup> and GFP<sup>high</sup>B220<sup>low</sup> populations were mostly composed of CD138<sup>+</sup> cells (<xref ref-type="fig" rid="fig2">Figure 2D,E</xref>). Identical results were found when defining PCs using in addition surface expression of CXCR4, a chemokine receptor that facilitates homing of PCs to the bone marrow (<xref ref-type="fig" rid="fig2">Figure 2D,E</xref>; <xref ref-type="bibr" rid="bib19">Hargreaves et al., 2001</xref>). Thus, increased GFP expression from the <italic>Jchain<sup>creERT2</sup></italic> allele associates with the loss of B220 and increased expression of PC-associated surface markers.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Jchain</italic> is expressed in a small fraction of GC B cells and in most plasma cells.</title><p>(<bold>A</bold>) Schematic of <italic>Jchain</italic> targeted allele Wtsi MGI:5633773. Rectangular boxes indicate exons, and exon number is on top; pink triangle indicates an FRT sequence; EGFPcre<sup>ERT2</sup> cassette contains a splice acceptor site (SA)-led EGFP-2A-creERT2 expression cassette followed by a poly-A tail inserted in the intron between exons 1 and 2; white triangle indicates a ROX sequence; orange rectangle indicates a promoter-driven puromycin resistance cassette; green triangle indicates loxP sequence. (<bold>B</bold>) Schematic of experimental procedure protocol. Mice carrying the <italic>Jchain</italic><sup>creERT2</sup> allele were immunized with sheep red blood cells (SRBC) intravenously (i.v.) on day 0 and spleens of mice were analyzed at day 12 post-immunization. (<bold>C</bold>) Gating strategy of populations by flow-cytometry according to the expression of GFP and B220 in mice carrying the <italic>Jchain</italic><sup>creERT2</sup> allele and wild-type B6 mice for a negative control of GFP expression. (<bold>D</bold>) Gating strategy by flow-cytometry for plasma cells within the GFP<sup>hi</sup>B220<sup>low</sup> population using CD138<sup>+</sup> and CD138<sup>+</sup>CXCR4<sup>+</sup> markers. (<bold>E</bold>) Cumulative data for CD138<sup>+</sup> and CD138<sup>+</sup>CXCR4<sup>+</sup>plasma cells analyzed as in (<bold>D</bold>). Top: fraction of CD138<sup>+</sup>plasma cells; bottom: fraction of CD138<sup>+</sup>CXCR4<sup>+</sup>plasma cells within the four populations defined by flow-cytometry according to the expression of GFP and B220 in mice carrying the <italic>Jchain</italic><sup>creERT2</sup> allele. (<bold>F</bold>) Gating strategy by flow-cytometry for total CD138<sup>+</sup> and CD138<sup>+</sup>CXCR4<sup>+</sup>plasma cells within GFP<sup>low</sup>B220<sup>hi</sup> population. The CD138<sup>neg</sup> cell fraction within the GFP<sup>low</sup>B220<sup>hi</sup> population was analyzed for the CD19 B cell marker and stained for CD38 and FAS to determine germinal center (GC) B cells. (<bold>G</bold>) Cumulative data for the frequency of GC B cells within the CD138<sup>neg</sup>GFP<sup>low</sup>B220<sup>hi</sup> population. Each symbol (E: n = 26, G: n = 26) represents an individual mouse; small horizontal lines indicate median, minimum, and maximum values. ***=p ≤ 0.001, ****=p ≤ 0.0001 (unpaired Student’s <italic>t</italic>-test). Data are representative of three independent experiments (<bold>E, G</bold>).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Frequency of plasma cells or B cells within the populations defined by GFP and B220 expression.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59850-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59850-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Cell marker enrichment within the GFP<sup>low</sup>B220<sup>hi</sup> population.</title><p>(<bold>A</bold>) Cumulative data for the frequency of GFP<sup>low</sup>B220<sup>hi</sup> (G<sup>low</sup>B<sup>hi</sup>) within live cells. (<bold>B</bold>) Cumulative data for the frequency of GC B cells within the CD138<sup>neg</sup>GFP<sup>low</sup>B220<sup>hi</sup> population. (<bold>C–D</bold>) Cumulative data for CD138<sup>+</sup> (<bold>C</bold>) and CD138<sup>+</sup>CXCR4<sup>+</sup> (<bold>D</bold>) cells within the GFP<sup>low</sup>B220<sup>hi</sup> population. Each symbol (n = 26) represents an individual mouse; small horizontal lines indicate median, minimum, and maximum values. ns = not significant, **=p ≤ 0.01, ***=p ≤ 0.001 (unpaired Student’s <italic>t</italic>-test). Data are representative of three independent experiments (<bold>A–D</bold>).</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Cell marker enrichment within the GFP<sup>low</sup>B220<sup>hi </sup>population.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59850-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59850-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title><italic>Jchain</italic> expression in multiple stages of B cell development and other cell lineages.</title><p>(<bold>A</bold>) Gating strategy by flow-cytometry for the B cell lineage in the spleen. Mice carrying the <italic>Jchain</italic><sup>creERT2</sup> and <italic>R26</italic><sup>lslRFP</sup> alleles were immunized with sheep red blood cells (SRBC) intravenously (i.v.) at day 0 and spleens were analyzed at day 12. Mice did not receive tamoxifen treatment. Cells were pre-gated on live singlets and for the expression of CD138 and CXCR4 markers. CD138<sup>+</sup>CXCR4<sup>+</sup> cells were defined as plasma cells (PC). Non-PCs positive for the CD19 and B220 markers were defined as B2 cells, whereas those cells displaying a CD19<sup>+</sup>B220<sup>low</sup> were defined as B1 cells. B1 cells were further characterized as B1a (CD5<sup>hi</sup>CD23<sup>neg</sup>) and B1b (CD5<sup>low</sup>CD23<sup>neg</sup>) cells. B2 cells were further delineated into marginal zone (MZ) B cells (CD21<sup>hi</sup>CD23<sup>int</sup>), T1 B cells (CD21<sup>low</sup>CD23<sup>low</sup>), T2 B cells (CD21<sup>int</sup>IgM<sup>hi</sup>CD23<sup>hi</sup>), and follicular B cells (Fo, CD21<sup>int</sup>IgM<sup>int</sup>CD23<sup>hi</sup>). Non MZ or T1 cells were gated for germinal center (GC) B cells (CD38<sup>low</sup>FAS<sup>high</sup>) and these were further delineated into dark zone GC B cells (CXCR4<sup>high</sup>CD86<sup>low</sup>) and light zone GC B cells (CXCR4<sup>low</sup>CD86<sup>high</sup>; <xref ref-type="bibr" rid="bib5">Bonami et al., 2014</xref>) (<bold>B</bold>) Cumulative data for the GFP<sup>+</sup> cell fraction within the B cell lineage in the spleen. Analyzed as in (<bold>A</bold>). (<bold>C</bold>) Cumulative data for the GFP<sup>+</sup> cell fraction in additional B cell lineage and non-B cell lineage populations in the spleen. Analyzed as in (<bold>A</bold>). (<bold>D</bold>) Gating strategy by flow-cytometry for the B cell lineage in the bone marrow. Mice carrying the <italic>Jchain</italic><sup>creERT2</sup> and <italic>R26</italic><sup>lslRFP</sup> alleles were immunized with sheep red blood cells (SRBC) intravenously (i.v.) at day 0 and spleens were analyzed at day 12. Mice did not receive tamoxifen treatment. Cells were pre-gated on live singlets and gated for CD138 and B220 expression. CD138<sup>+</sup>B220<sup>low</sup> cells were defined as plasma cells (PCs). Non-PCs positive for the CD19 and B220 markers were examined and further delineated to immature B cells (IgM<sup>+</sup>CD43<sup>neg</sup>), Pre-B cells (fraction D; IgM<sup>neg</sup>CD43<sup>neg</sup>), and Pro-B cells (IgM<sup>neg</sup>CD43<sup>+</sup>). Pro B cells were further sub-divided into Hardy fraction A (BP1<sup>neg</sup>CD24<sup>neg</sup>), fraction B (BP1<sup>neg</sup>CD24<sup>+</sup>), fraction C (BP1<sup>+</sup>CD24<sup>neg</sup>) and fraction C’ (BP1<sup>+</sup>CD24<sup>+</sup>). (<bold>E</bold>) Cumulative data for the GFP<sup>+</sup> cell fraction in the B cell lineage and in plasma cells in the bone marrow. Analyzed as in (<bold>D</bold>). Each symbol (B: n = 5, C: n = 12, E: n = 5) represents an individual mouse; small horizontal lines indicate median, minimum, and maximum values. Data are representative of three independent experiments (<bold>B, C, E</bold>).</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Frequency of GFP<sup>+</sup> cells within the various immune populations in the spleen and bone marrow.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59850-fig2-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59850-fig2-figsupp2-v2.tif"/></fig></fig-group><p>We further investigated the cellular composition of the GFP<sup>low</sup>B220<sup>high</sup> population that contained the fewest CD138<sup>+</sup> cells (1% to 20%; <xref ref-type="fig" rid="fig2">Figure 2E</xref>). The gate defining this population was designed to not disregard the occurrence of cells with a low-level of GFP expression in mice carrying the <italic>Jchain</italic><sup>creERT2</sup> allele. However, such strategy inevitably led to the inclusion of a small fraction of ‘false’ GFP positive cells as indicated by the analysis of control mice (wild-type C57BL/6) that are GFP negative (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Still, the fraction of cells within the GFP<sup>lo</sup>B220<sup>hi</sup> population was significantly enriched in <italic>Jchain</italic><sup>creERT2</sup> mice compared to control (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Also above background, we found that virtually all CD138<sup>neg</sup> cells within the GFP<sup>low</sup>B220<sup>high</sup> population of mice with the <italic>Jchain</italic><sup>creERT2</sup> allele expressed the B cell marker CD19 (<xref ref-type="fig" rid="fig2">Figure 2F</xref>), and in agreement with <italic>Jchain</italic> gene expression analysis (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) these cells mostly represented germinal center (GC) B cells (CD38<sup>low</sup>FAS<sup>high</sup>; <xref ref-type="fig" rid="fig2">Figure 2F,G</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). By contrast, only 30% of <italic>Jchain</italic><sup>creERT2</sup> mice had above background enrichment for CD138<sup>+</sup> and CD138<sup>+</sup>CXCR4<sup>+</sup> expressing cells within the GFP<sup>low</sup>B220<sup>high</sup> population (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). These data prompts caution when using the gate defining the GFP<sup>low</sup>B220<sup>high</sup> population to study enrichment for PC markers in mice carrying <italic>Jchain</italic><sup>creERT2</sup> allele, as it may contain an unacceptable level of contamination by non-GFP positive cells.</p><p>We further performed analyses in the spleen and bone marrow of 12 day SRBC immunized mice heterozygous for the <italic>Jchain</italic><sup>creERT2</sup> allele in which precursors and mature B cells, and non-B cell populations were first defined using surface markers and the fraction of GFP expressing cells within those populations determined (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). We found that most PCs in the spleen and bone marrow expressed GFP (CD138<sup>+</sup>CXCR4<sup>+</sup>, 60 to 90%; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). We also observed that a minor fraction of B1b cells (0 to 6%) in the spleen expressed GFP (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>), possibly in agreement with the knowledge that B1b cells are prone to differentiate into PCs and are a source of IgM antibodies during T cell independent responses (<xref ref-type="bibr" rid="bib1">Alugupalli et al., 2004</xref>). Collectively these data confirmed at the single cell level the gene expression analysis using bulk populations (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) and suggested that <italic>Jchain</italic> expression is highly enriched in PCs.</p></sec><sec id="s2-3"><title><italic>Jchain</italic> expression correlates with that of IRF4 and BLIMP1</title><p>IRF4 and BLIMP1 transcription factors play an essential role in PC differentiation (<xref ref-type="bibr" rid="bib26">Kallies et al., 2007</xref>; <xref ref-type="bibr" rid="bib28">Klein et al., 2006</xref>; <xref ref-type="bibr" rid="bib55">Sciammas et al., 2006</xref>; <xref ref-type="bibr" rid="bib58">Shapiro-Shelef et al., 2003</xref>). We analyzed the spleen of 12 day SRBC immunized mice heterozygous for the <italic>Jchain</italic><sup>creERT2</sup> allele and determined the expression pattern of IRF4 and BLIMP1 in the populations defined by varied GFP and B220 expression (<xref ref-type="fig" rid="fig2">Figures 2C</xref> and <xref ref-type="fig" rid="fig3">3A,B</xref>). The GFP<sup>neg</sup>B220<sup>neg</sup> population was virtually devoid of cells with BLIMP1 and IRF4 expression (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In 30% of mice carrying the <italic>Jchain</italic><sup>creERT2</sup> allele we found above background enrichment for BLIMP1<sup>+</sup>IRF4<sup>+</sup> cells within the GFP<sup>low</sup>B220<sup>high</sup> population (<xref ref-type="fig" rid="fig3">Figure 3D,E</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). However, most GFP<sup>low</sup>B220<sup>high</sup> cells were negative for BLIMP1 and IRF4, suggesting that <italic>Jchain</italic> expression precedes that of IRF4 and BLIMP1, as previously observed in in vitro cultures of <italic>Blimp1</italic> deficient B cells (<xref ref-type="bibr" rid="bib26">Kallies et al., 2007</xref>). Still, <italic>Jchain</italic> expression as measured by GFP strongly correlated with that of IRF4 and BLIMP1 given that the vast majority of cells within the GFP<sup>int</sup>B220<sup>int</sup> and GFP<sup>high</sup>B220<sup>low</sup> populations were BLIMP1<sup>+</sup>IRF4<sup>+</sup> (<xref ref-type="fig" rid="fig3">Figure 3D and E</xref>). Overall, we identified an in vivo population of cells in which <italic>Jchain</italic> expression preceded that of IRF4 and BLIMP1, possibly representing PC precursors. As PC differentiation ensued, <italic>Jchain</italic> expression correlated highly with the expression of the transcription factors BLIMP1 and IRF4 that are critical for the establishment of the PC program.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>Jchain</italic> expression correlates with that of IRF4 and BLIMP1.</title><p>(<bold>A</bold>) Schematic of experimental procedure protocol. Mice carrying the <italic>Jchain</italic><sup>creERT2</sup> allele were immunized with sheep red blood cells (SRBC) intravenously (i.v.) on day 0 and spleens of mice were analyzed at day 12 post-immunization. (<bold>B</bold>) Gating strategy of populations by flow-cytometry according to the expression of GFP and B220 in mice carrying the <italic>Jchain</italic><sup>creERT2</sup> allele. (<bold>C</bold>) Gating strategy for IRF4 and BLIMP1 expression by flow-cytometry within the GFP<sup>neg</sup>B220<sup>neg</sup> population. (<bold>D</bold>) Gating strategy for IRF4 and BLIMP1 expression by flow-cytometry within GFP<sup>low</sup>B220<sup>hi</sup>, GFP<sup>int</sup>B220<sup>int</sup>, and GFP<sup>hi</sup>B220<sup>low</sup> populations, defined as in (<bold>B</bold>). (<bold>E</bold>) Cumulative data for the frequency of BLIMP1<sup>+</sup>IRF4<sup>+</sup> cells within the four populations defined as in (<bold>B</bold>). Each symbol in (E: n = 26) represents an individual mouse; small horizontal lines indicate median, minimum, and maximum values. ns = not significant, ***=p ≤ 0.001, ****=p ≤ 0.0001 (unpaired Student’s <italic>t</italic>-test). Data are representative of three independent experiments (<bold>E</bold>).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Frequency of BLIMP1<sup>+</sup>IRF4<sup>+</sup> cells within the populations defined by GFP and B220 expression.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59850-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59850-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>BLIMP1<sup>+</sup>IRF4<sup>+</sup> cells within the GFP<sup>low</sup>B220<sup>hi</sup> population.</title><p>Cumulative data for the frequency of BLIMP1<sup>+</sup>IRF4<sup>+</sup> cells within GFP<sup>low</sup>B220<sup>hi</sup> cells. Each symbol (n = 26) represents an individual mouse; small horizontal lines indicate median, minimum, and maximum values. ns = not significant (unpaired Student’s <italic>t</italic>-test). Data are representative of three independent experiments.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Frequency of BLIMP1<sup>+</sup>IRF4<sup>+</sup> cells within the GFP<sup>low</sup>B220<sup>hi</sup> population.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59850-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59850-fig3-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title><italic>Jchain</italic><sup>creERT2</sup> mediated genetic manipulation is effective only in plasma cells</title><p>Next, we sought to determine whether the <italic>Jchain</italic><sup>creERT2</sup> allele could be used to perform genetic manipulation in PCs. For that we generated compound mutant mice carrying the <italic>Jchain</italic><sup>creERT2</sup> allele and a Rosa 26 allele in which RFP expression is conditional to cre-mediated recombination of a loxP-STOP-loxP cassette (<italic>R26</italic><sup>lslRFP</sup>; <xref ref-type="bibr" rid="bib35">Luche et al., 2007</xref>). In the <italic>Jchain</italic><sup>creERT2</sup> allele, cre is fused to an estrogen binding domain (ERT2) that sequesters cre in the cytoplasm through the binding to HSP90 (<xref ref-type="bibr" rid="bib17">Feil et al., 2009</xref>). Addition of tamoxifen displaces the creERT2-HSP90 complex allowing effective nuclear import of creERT2 and its access to loxP flanked DNA sequences (<xref ref-type="fig" rid="fig4">Figure 4A</xref>; <xref ref-type="bibr" rid="bib17">Feil et al., 2009</xref>). We first performed an in vitro experiment using a classical plasmablast (B220<sup>low</sup>CD138<sup>+</sup>) differentiation assay in which B cells purified from mice carrying the <italic>Jchain</italic><sup>creERT2</sup> and <italic>R26</italic><sup>lslRFP</sup> alleles were cultured with LPS (<xref ref-type="bibr" rid="bib3">Andersson et al., 1972</xref>) in the presence or absence of 4-OH tamoxifen. GFP expression was highly enriched in plasmablasts compared to B cells and RFP expression was only observed upon addition of 4-OH tamoxifen to the cell culture, and that occurred virtually only in plasmablasts (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). This data suggested that creERT2 was specifically expressed by plasmablasts and effectively retained in the cytoplasm in the absence of 4-OH tamoxifen.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Jchain</italic><sup>creERT2</sup> mediated genetic manipulation is effective only in plasma cells.</title><p>(<bold>A</bold>) Schematic of experimental procedure protocol. Mice carrying the <italic>Jchain</italic><sup>creERT2</sup> and <italic>R26</italic><sup>lslRFP</sup> alleles were immunized with sheep red blood cells (SRBC) intravenously (i.v.) on day 0 and spleens (top) and bone marrow (bottom) of mice were analyzed at day 12 post-immunization. A group of mice received tamoxifen treatment for four consecutive days from day 7 to day 10 after immunization. (<bold>B</bold>) Gating strategy of populations by flow-cytometry in the spleen (top) and bone marrow (bottom) according to the expression of GFP and B220 in mice carrying the <italic>Jchain</italic><sup>creERT2</sup> allele. (<bold>C</bold>) Gating strategy for GFP and RFP expression by flow-cytometry in the four populations defined as in (<bold>B</bold>). Top: spleen; bottom: bone marrow. (<bold>D</bold>) Cumulative data for the frequency and number of GFP<sup>+</sup>RFP<sup>+</sup> cells within GFP<sup>neg</sup>B220<sup>neg</sup>, GFP<sup>low</sup>B220<sup>hi</sup>, GFP<sup>int</sup>B220<sup>int</sup>, and GFP<sup>hi</sup>B220<sup>low</sup> populations, defined as in (<bold>B</bold>). Top: spleen; bottom: bone marrow. Each symbol (D: n = 14) represents an individual mouse; small horizontal lines indicate median, minimum, and maximum values. ns = not significant, *=p ≤ 0.05, **=p ≤ 0.01, ***=p ≤ 0.001, ****=p ≤ 0.0001 (unpaired Student’s <italic>t</italic>-test). Data are representative of three independent experiments (<bold>D</bold>).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Frequency and number of GFP<sup>+</sup>RFP<sup>+</sup> cells within the populations defined by GFP and B220 expression.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59850-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59850-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title><italic>Jchain</italic><sup>creERT2</sup> mediated genetic manipulation in vitro.</title><p>(<bold>A</bold>) Gating strategy by flow-cytometry for GFP and RFP expression within CD19<sup>+</sup>B220<sup>+</sup> B cells and B220<sup>low</sup>CD138<sup>+</sup> plasmablasts. Splenic B cells from unmanipulated mice carrying the <italic>Jchain</italic><sup>creERT2</sup> and <italic>R26</italic><sup>lslRFP</sup> alleles were enriched using CD43 negative depletion (MACS) and cultured in vitro in the presence of LPS and 4-hydroxytamoxifen (4-OH-TAM). Cells were analyzed 48, 72, and 96 hr time-points for GFP and RFP expression by flow-cytometry. Data from 96 hr analysis of a B cell culture with LPS and 1 μM 4-OH-TAM is shown as example. (<bold>B</bold>) Cumulative data for fractions of GFP<sup>neg</sup>RFP<sup>neg</sup>, GFP<sup>+</sup>RFP<sup>neg</sup>, GFP<sup>+</sup>RFP<sup>+</sup> cells within B cells. Analyzed as in (<bold>A</bold>). (<bold>C</bold>) Cumulative data for fractions of GFP<sup>neg</sup>RFP<sup>neg</sup>, GFP<sup>+</sup>RFP<sup>neg</sup>, GFP<sup>+</sup>RFP<sup>+</sup> cells within plasmablasts. Analyzed as in (<bold>A</bold>).</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Fractions of populations defined by GFP and RFP expression within B cells or plasmablasts in vitro.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59850-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59850-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>The cre activity of the <italic>Jchain</italic><sup>creERT2</sup> allele is tightly regulated.</title><p>(<bold>A</bold>) Cumulative data for fraction of GFP<sup>+</sup>RFP<sup>+</sup> cells within the B cell lineage in the spleen. Analyzed as in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref> panel (<bold>A</bold>). (<bold>B</bold>) Cumulative data for fraction of GFP<sup>+</sup>RFP<sup>+</sup> cells in additional B cell lineage and non-B cell lineage populations in the spleen. Analyzed as in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref> panel (<bold>A</bold>). (<bold>C</bold>) Cumulative data for fraction of GFP<sup>+</sup>RFP<sup>+</sup> cells in the B cell lineage and in plasma cells in the bone marrow. Analyzed as in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref> panel (<bold>D</bold>). Each symbol (A: n = 5, B: n = 12, C: n = 5) represents an individual mouse; small horizontal lines indicate median, minimum, and maximum values. Data are representative of three independent experiments (<bold>A, B, C</bold>).</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Frequency of GFP<sup>+</sup>RFP<sup>+</sup> cells within the various immune populations in the spleen and bone marrow.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59850-fig4-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59850-fig4-figsupp2-v2.tif"/></fig></fig-group><p>Similar observations were made in mice carrying the <italic>Jchain</italic><sup>creERT2</sup> and <italic>R26</italic><sup>lslRFP</sup> alleles in vivo. In the absence of tamoxifen administration RFP expressing cells were not detected, confirming the in vitro results and supporting that the <italic>Jchain</italic><sup>creERT2</sup> allele was not ‘leaky’ in the control of cre activity (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). Next, we immunized mice carrying <italic>Jchain</italic><sup>creERT2</sup> and <italic>R26</italic><sup>lslRFP</sup> alleles and administered tamoxifen on days 7, 8, 9, and 10 followed by analysis of the spleen and bone marrow at day 12 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Analyses of the populations defined by varied GFP and B220 surface expression (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig4">4B</xref>) revealed that a small fraction of GFP<sup>low</sup>B220<sup>high</sup> cells were positive for RFP in the spleen (median ~2%) and in the bone marrow (median ~1.2%; <xref ref-type="fig" rid="fig4">Figure 4C,D</xref>). In contrast, cre mediated recombination and as consequence RFP expression occurred in ~37% and~31% of GFP<sup>int</sup>B220<sup>int</sup> in the spleen and bone marrow, respectively, and the vast majority of cells within the GFP<sup>high</sup>B220<sup>low</sup> population had undergone cre mediated recombination and were RFP positive (~76% in the spleen, and ~88% in the bone marrow, median; <xref ref-type="fig" rid="fig4">Figure 4C,D</xref>). These data showed that <italic>Jchain</italic><sup>creERT2</sup> mediated cre-recombination was only effective in PC populations validating it as a tool to specifically perform genetic manipulation of PCs.</p></sec><sec id="s2-5"><title>Genetic manipulation using <italic>Jchain</italic><sup>creERT2</sup> occurs across immunoglobulin isotypes</title><p>IgG1 does not multimerize, and due to differences in its secretory tail to that of IgA and IgM, JCHAIN does not associate with IgG1 (<xref ref-type="bibr" rid="bib24">Johansen et al., 2000</xref>). Currently it is suggested that <italic>Jchain</italic> expression occurs in all PCs regardless of isotype (<xref ref-type="bibr" rid="bib10">Castro and Flajnik, 2014</xref>; <xref ref-type="bibr" rid="bib24">Johansen et al., 2000</xref>; <xref ref-type="bibr" rid="bib40">Mather et al., 1981</xref>). However, this has not been demonstrated at the single cell level. We performed experiments that investigated whether <italic>Jchain</italic><sup>creERT2</sup> allele GFP expression and cre-mediated loxP recombination occurred in PCs across immunoglobulin isotypes. For that we analyzed the spleen, mesenteric lymph node (mLN), Peyer’s patches and bone marrow of younger (15 weeks) and older (30 weeks) mice carrying the <italic>Jchain</italic><sup>creERT2</sup> and <italic>R26</italic><sup>lslRFP</sup> alleles. These mice were immunized with SRBC and administered with tamoxifen on days 7, 8, 9, and 10 followed by analysis at day 12 (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). We first analyzed total PCs (B220<sup>low</sup>CD138<sup>+</sup>), and within these cells those that expressed GFP (RFP<sup>+</sup> and RFP<sup>neg</sup>) and GFP<sup>+</sup>RFP<sup>+</sup> cells (cre recombined) to determine the proportions of IgA, IgM, and IgG1 expressing cells using intracellular stain (<xref ref-type="fig" rid="fig5">Figure 5B–D</xref>). Overall, we found only small differences. Analysis of spleens of 15-week-old mice revealed a slight increase in the percentage of IgA<sup>+</sup> cells within the GFP<sup>+</sup>RFP<sup>+</sup> PCs only when compared to total PCs (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). A similar trend was observed when analyzing Peyer’s patches of 15-week-old mice (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). However, in the other analyzed tissues of these mice we did not observe differences in the proportion of IgA, nor for IgM and IgG1 in any of the tissues analyzed (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). 30-week-old mice showed a slight increase in the percentage of splenic IgM<sup>+</sup> cells within the GFP<sup>+</sup>RFP<sup>+</sup> PCs only when compared to total PCs, and for IgA<sup>+</sup> in the mLN (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). No significant difference was observed in 30-week-old mice for the proportion of IgM or IgA in any of the other analyzed tissues, and in none of the analyzed tissues for IgG1 (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). Taken together, these data suggested that <italic>Jchain</italic> expression is not overly represented in IgA or IgM expressing PCs compared to IgG1<sup>+</sup> PCs. We concluded that <italic>Jchain</italic><sup>creERT2</sup> mediated cre-loxP recombination occurs across immunoglobulin isotypes and thus that the <italic>Jchain</italic><sup>creERT2</sup> allele is a useful tool for genetic manipulation also of IgG1 expressing PCs.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Genetic manipulation using <italic>Jchain</italic><sup>creERT2</sup> occurs across immunoglobulin isotypes.</title><p>(<bold>A</bold>) Schematic of experimental procedure protocol. Mice carrying the <italic>Jchain</italic><sup>creERT2</sup> and <italic>R26</italic><sup>lslRFP</sup> alleles were immunized with sheep red blood cells (SRBC) intravenously (i.v.) on day 0 and spleens, mesenteric lymph nodes (mLN), Peyer’s patches, and bone marrows of mice were analyzed at day 12 post-immunization. Mice received tamoxifen treatment for four consecutive days from day 7 to day 10 after immunization. (<bold>B</bold>) Gating strategy by flow-cytometry for intracellular and extracellular expression of IgG1, IgM and IgA within total B220<sup>low</sup>CD138<sup>+</sup>plasma cells. Analysis in the spleen is provided as example. (<bold>C</bold>) Gating strategy by flow-cytometry for intracellular and extracellular expression of IgG1, IgM, and IgA within B220<sup>low</sup>CD138<sup>+</sup>GFP<sup>+</sup> (RFP<sup>+</sup> and RFP<sup>neg</sup>) plasma cells. Analysis in the spleen is provided as example. (<bold>D</bold>) Gating strategy by flow-cytometry for intracellular and extracellular expression of IgG1, IgM, and IgA within B220<sup>low</sup>CD138<sup>+</sup>GFP<sup>+</sup>RFP<sup>+</sup>plasma cells. Analysis in the spleen is provided as example. (<bold>E</bold>) Cumulative data for the fractions of IgA, IgM or IgG1 expressing cells within total plasma cells (PC) (black, B220<sup>low</sup>CD138<sup>+</sup>), GFP<sup>+</sup> (RFP<sup>+</sup> and RFP<sup>neg</sup>) plasma cells (green, B220<sup>low</sup>CD138<sup>+</sup>GFP<sup>+</sup>), and GFP<sup>+</sup>RFP<sup>+</sup>plasma cells (orange, B220<sup>low</sup>CD138<sup>+</sup>GFP<sup>+</sup>RFP<sup>+</sup>) at 15 weeks of age. (<bold>F</bold>) Cumulative data for the fractions of IgA, IgM, or IgG1 expressing cells within total plasma cells (PC) (black, B220<sup>low</sup>CD138<sup>+</sup>), GFP<sup>+</sup> (RFP<sup>+</sup> and RFP<sup>neg</sup>) plasma cells (green, B220<sup>low</sup>CD138<sup>+</sup>GFP<sup>+</sup>), and GFP<sup>+</sup>RFP<sup>+</sup>plasma cells (orange, B220<sup>low</sup>CD138<sup>+</sup>GFP<sup>+</sup>RFP<sup>+</sup>) at 30 weeks of age. Each symbol (E: n = 5–6, F: n = 5–6) represents an individual mouse; small horizontal lines indicate median, minimum, and maximum values. ns = not significant, *=p ≤ 0.05 (unpaired Student’s <italic>t</italic>-test). Data are representative of three independent experiments (<bold>E, F</bold>).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Fractions of IgA, IgM or IgG1-expressing cells within populations of plasma cells defined by GFP and RFP expression at various immune sites.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59850-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59850-fig5-v2.tif"/></fig></sec><sec id="s2-6"><title>Inclusive analysis of plasma cell dynamics reveals tissue-specific homeostatic population turnover</title><p>Understanding of the PC population turnover is lacking. Multiple investigations have been performed to determine the PC lifespan using primarily nucleotide analog incorporation into the DNA. These studies have provided fundamental insights on PC maintenance and currently it is accepted that a fraction of PCs in the mouse survives for periods longer than 3 months (<xref ref-type="bibr" rid="bib21">Ho et al., 1986</xref>; <xref ref-type="bibr" rid="bib32">Lemke et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Manz et al., 1998</xref>; <xref ref-type="bibr" rid="bib38">Manz et al., 1997</xref>; <xref ref-type="bibr" rid="bib61">Slifka et al., 1998</xref>). However, given the quiescent nature of PCs and that nucleotide analog methodology requires cell division, these methods are not appropriate to study global population turnover in tissues. We investigated the suitability of the <italic>Jchain</italic><sup>creERT2</sup> allele to determine the turnover of the PC population in the spleen and bone marrow. We immunized mice carrying the <italic>Jchain</italic><sup>creERT2</sup> and <italic>R26</italic><sup>lslRFP</sup> alleles at two time-points spaced by a period of 21 days (<xref ref-type="fig" rid="fig6">Figure 6A</xref>; <xref ref-type="bibr" rid="bib8">Calado et al., 2010</xref>). Thirty days after the secondary immunization (day 51) we administered tamoxifen for five consecutive days to genetically label PCs (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Next, we determined the absolute cell number of total PCs, of GFP<sup>+</sup> cells (RFP<sup>+</sup> and RFP<sup>neg</sup>), GFP<sup>+</sup>RFP<sup>+</sup> cells (cre recombined), and GFP<sup>+</sup>RFP<sup>neg</sup> cells (not cre recombined). We found that over a period of 5 months the cell number of total and GFP<sup>+</sup> PCs remained constant over time (<xref ref-type="fig" rid="fig6">Figure 6B,C</xref>). By contrast, the cell number of GFP<sup>+</sup>RFP<sup>+</sup> cells decayed (<xref ref-type="fig" rid="fig6">Figure 6B,C</xref>) in both the spleen (t<sub>1/2</sub> ~31.63d) and bone marrow (t<sub>1/2</sub> ~251.93d; <xref ref-type="fig" rid="fig6">Figure 6D,E</xref>). These results may agree with the knowledge that the half-life of PC residence differs between spleen and the bone marrow (<xref ref-type="bibr" rid="bib63">Sze et al., 2000</xref>). Notably, analysis of the GFP<sup>+</sup>RFP<sup>neg</sup> cell numbers revealed that the emergence of these cells paralleled that observed for the decay in cell numbers of GFP<sup>+</sup>RFP<sup>+</sup> cells (<xref ref-type="fig" rid="fig6">Figure 6B,C</xref>) both in the spleen (t<sub>1/2</sub> ~20.20d) and bone marrow (t<sub>1/2</sub> ~190.19d; <xref ref-type="fig" rid="fig6">Figure 6F,G</xref>). These data indicated that the turnover of the PC population is homeostatically regulated in a tissue-specific manner.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Inclusive analysis of plasma cell dynamics reveals tissue-specific homeostatic population turnover.</title><p>(<bold>A</bold>) Schematic of the experimental procedure protocol. Mice carrying the <italic>Jchain</italic><sup>creERT2</sup> and <italic>R26</italic><sup>lslRFP</sup> alleles were immunized twice with sheep red blood cells (SRBC) intravenously (i.v.) on day 0 and day 21. Mice received tamoxifen treatment for five consecutive days from day 51 to 55 after the first immunization. Spleens and bone marrow of mice were analyzed at day 5, 2-month, and 5-month timepoints after the last tamoxifen administration. (<bold>B</bold>) Cumulative data for the absolute cell numbers of total PCs, of GFP<sup>+</sup> cells (RFP<sup>+</sup> and RFP<sup>neg</sup>), GFP<sup>+</sup>RFP<sup>+</sup> cells (cre recombined), and GFP<sup>+</sup>RFP<sup>neg</sup> cells (not cre recombined) in the spleen. (<bold>C</bold>) Cumulative data for the absolute cell numbers of total PCs, of GFP<sup>+</sup> cells (RFP<sup>+</sup> and RFP<sup>neg</sup>), GFP<sup>+</sup>RFP<sup>+</sup> cells (cre recombined), and GFP<sup>+</sup>RFP<sup>neg</sup> cells (not cre recombined) in the bone marrow. (<bold>D</bold>) Graphical representation of half-life (t<sub>1/2</sub>) of GFP<sup>+</sup>RFP<sup>+</sup>CD138<sup>+</sup>CXCR4<sup>+</sup>plasma cells in the spleen using the data presented in (<bold>B</bold>). Graphing of the best-fit curve was performed using the GraphPad Prism eight software. (<bold>E</bold>) Graphical representation of half-life (t<sub>1/2</sub>) of GFP<sup>+</sup>RFP<sup>+</sup>CD138<sup>+</sup>CXCR4<sup>+</sup>plasma cells in the bone marrow using the data presented in (<bold>C</bold>). Graphing of the best-fit curve was performed using the GraphPad Prism eight software. (<bold>F</bold>) Graphical representation of half-life (t<sub>1/2</sub>) of GFP<sup>+</sup>RFP<sup>neg</sup>CD138<sup>+</sup>CXCR4<sup>+</sup>plasma cells in the spleen using the data presented in (<bold>B</bold>). Graphing of the best-fit curve was performed using the GraphPad Prism eight software. (<bold>G</bold>) Graphical representation of half-life (t<sub>1/2</sub>) of GFP<sup>+</sup>RFP<sup>neg</sup>CD138<sup>+</sup>CXCR4<sup>+</sup>plasma cells in the bone marrow using the data presented in (<bold>C</bold>). Graphing of the best-fit curve was performed using the GraphPad Prism eight software. Each symbol (B-G: 5D n = 6; 2M n = 5; 5M n = 9) represents an individual mouse; small horizontal lines indicate median, minimum, and maximum values. ns = not significant, *=p ≤ 0.05 **=p ≤ 0.01, ***=p ≤ 0.001, ****=p ≤ 0.0001 (unpaired Student’s <italic>t</italic>-test). Data are representative of three independent experiments (<bold>B, C</bold>).</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Absolute cell numbers of plasma cell populations defined by GFP and RFP expression in the spleen and bone marrow over time.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-59850-fig6-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59850-fig6-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Plasma cells (PC)s are an essential component of the adaptive immune system. However, compared to other B cell lineage populations the molecular analysis of PC gene function in vivo has lagged behind. One underlying cause is the lack of tools for specific genetic manipulation of PCs, something available for B cells since 1997, more than 20 years ago (<xref ref-type="bibr" rid="bib51">Rickert et al., 1997</xref>), and more recently for B cells at multiple stages of development (<xref ref-type="bibr" rid="bib6">Boross et al., 2009</xref>; <xref ref-type="bibr" rid="bib9">Casola et al., 2006</xref>; <xref ref-type="bibr" rid="bib11">Croker et al., 2004</xref>; <xref ref-type="bibr" rid="bib12">Crouch et al., 2007</xref>; <xref ref-type="bibr" rid="bib14">de Boer et al., 2003</xref>; <xref ref-type="bibr" rid="bib15">Dogan et al., 2009</xref>; <xref ref-type="bibr" rid="bib16">Düber et al., 2009</xref>; <xref ref-type="bibr" rid="bib18">Georgiades et al., 2002</xref>; <xref ref-type="bibr" rid="bib22">Hobeika et al., 2006</xref>; <xref ref-type="bibr" rid="bib30">Kraus et al., 2004</xref>; <xref ref-type="bibr" rid="bib31">Kwon et al., 2008</xref>; <xref ref-type="bibr" rid="bib43">Moriyama et al., 2014</xref>; <xref ref-type="bibr" rid="bib53">Robbiani et al., 2008</xref>; <xref ref-type="bibr" rid="bib54">Schweighoffer et al., 2013</xref>; <xref ref-type="bibr" rid="bib60">Shinnakasu et al., 2016</xref>; <xref ref-type="bibr" rid="bib65">Weber et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Yasuda et al., 2013</xref>).</p><p>Here we used a systematic analysis of PC-associated factors for which expression is increased during PC differentiation (<italic>Xbp1</italic>, <italic>Jchain</italic>, <italic>Scd1</italic>, <italic>Irf4</italic>, and <italic>Prdm1</italic>) with the aim of identifying suitable candidates for the generation of PC-specific tools. <italic>Blimp1</italic>, a critical transcription factor for the establishment of the PC program, displayed an expression pattern unspecific to PCs. This was unsurprising given the knowledge that <italic>Blimp1</italic> is expressed by other hematopoietic and non-hematopoietic cells (<xref ref-type="bibr" rid="bib25">John and Garrett-Sinha, 2009</xref>), including germ cells (<xref ref-type="bibr" rid="bib47">Ohinata et al., 2005</xref>). Among the analyzed factors we found that <italic>Jchain</italic> displayed the highest RNA expression level in PCs and had the most PC-specific expression pattern. We considered <italic>Jchain</italic> to be the most suitable candidate for the generation of PC-specific tools. Next, we searched among alleles generated by the EUCOMMTools consortium and identified a <italic>Jchain</italic><sup>creERT2</sup> allele which through a comprehensive series of experiments we validated for specific genetic manipulation of PCs.</p><p>GFP expression as a reporter for <italic>Jchain</italic> was expressed in a very small subset of B cells (&lt;2%, primarily GC B cells) and in most plasma cells. The GFP expressing B cells were mostly negative for BLIMP1 and IRF4 expression. This data agrees with previous work using in vitro cultures of <italic>Blimp1</italic> deficient B cells suggesting that the initiation of <italic>Jchain</italic> expression does not require BLIMP1 (<xref ref-type="bibr" rid="bib26">Kallies et al., 2007</xref>). Thus, the identified population of cells in vivo marked by low GFP expression and high surface expression of B220 (GFP<sup>low</sup>B220<sup>hi</sup>), possibly contains PC precursor cells and future analysis may provide information on the mechanisms underlying the very first steps of PC differentiation. It is important to note, however, that the analysis of the GFP<sup>low</sup>B220<sup>hi</sup> population requires caution as it contains false GFP positive cells (i.e. background cells). If the underlying reason for the false GFP positivity within the GFP<sup>low</sup>B220<sup>hi</sup> population is autofluorescence; a common issue when GFP is weakly expressed because autofluorescence typically displays similar excitation and emission characteristics to GFP (<xref ref-type="bibr" rid="bib57">Shapiro, 1995</xref>; approaches that quench autofluorescence may reduce or abrogate background; <xref ref-type="bibr" rid="bib59">Shilova et al., 2017</xref>). Alternatively, the experimenter may design a more stringent gate, possibly increasing specificity and thus reducing contamination as long as the loss of a fraction of lowly expressing GFP cells is acceptable and consideration is taken that such stringency may itself introduce bias in the analysis.</p><p><italic>Jchain</italic><sup>creERT2</sup> mediated genetic manipulation was only effective in PCs and data of others deposited in bioRxiv during the revision of this work supports this finding (<xref ref-type="bibr" rid="bib4">Ayala et al., 2020</xref>). In the <italic>Jchain</italic><sup>creERT2</sup> allele GFP and cre<sup>ERT2</sup> are linked by a self-cleaving 2A peptide that ensures a near equitable co-expression of the proteins (<xref ref-type="bibr" rid="bib64">Szymczak et al., 2004</xref>). As consequence, it is likely that the effectiveness of cre recombination correlates with the level of cre<sup>ERT2</sup> expression because PCs expressed the highest level of <italic>Jchain</italic>, as suggested by GFP expression. Of note, the <italic>Jchain</italic><sup>creERT2</sup> allele analyzed in this work retained the puromycin selection cassette that is flanked by rox recombination sites. This knowledge should be taken in consideration in future experiments involving compound mutant mice that make use of dre recombinase (<xref ref-type="bibr" rid="bib2">Anastassiadis et al., 2009</xref>). On occasion it has been observed that retention of the selection cassette reduces gene expression of the targeted locus (<xref ref-type="bibr" rid="bib42">Meyers et al., 1998</xref>; <xref ref-type="bibr" rid="bib44">Nagy et al., 1998</xref>). Thus, inadvertent or intentional removal of the puromycin selection cassette may increase cre<sup>ERT2</sup> expression, including in B cells, possibly reducing the PC specificity of <italic>Jchain</italic><sup>creERT2</sup> mediated genetic manipulation. Finally, in the <italic>Jchain</italic><sup>creERT2</sup> allele the expression of <italic>Jchain</italic> is interrupted by a GFP-2A-cre<sup>ERT2</sup> cassette and induction of cre-mediated recombination deletes <italic>Jchain</italic> exon two that is loxP-flanked. It was previously shown that heterozygous deletion of <italic>Jchain</italic> displayed an intermediate phenotype to that of knockout mice (<xref ref-type="bibr" rid="bib36">Lycke et al., 1999</xref>). This knowledge must be considered when performing <italic>Jchain</italic><sup>creERT2</sup> mediated genetic manipulation, including the need to use the <italic>Jchain</italic><sup>creERT2</sup> allele without the targeted manipulation as control, and the utility of the <italic>Jchain</italic><sup>creERT2</sup> allele in homozygosity. Future iterations of <italic>Jchain</italic><sup>creERT2</sup> alleles in which JCHAIN protein expression is preserved should be considered.</p><p>It is currently thought that <italic>Jchain</italic> expression occurs in all PCs regardless of their isotype (<xref ref-type="bibr" rid="bib10">Castro and Flajnik, 2014</xref>; <xref ref-type="bibr" rid="bib24">Johansen et al., 2000</xref>; <xref ref-type="bibr" rid="bib40">Mather et al., 1981</xref>). The characterization of the <italic>Jchain</italic><sup>creERT2</sup> allele demonstrated at the single cell level that <italic>Jchain</italic> expression indeed occurs in PCs across immunoglobulin isotypes. However, we observed the occurrence of both GFP<sup>+</sup> PCs and of a smaller fraction of GFP<sup>neg</sup> PCs, which in a first approximation suggested that <italic>Jchain</italic><sup>neg</sup> PCs exist. Nevertheless, it is important to consider that although GFP is driven by the endogenous <italic>Jchain</italic> promoter, it does not directly measure JCHAIN itself at the transcriptional and translational level. Further investigation of GFP<sup>+</sup> and GFP<sup>neg</sup> PCs in mice carrying the <italic>Jchain</italic><sup>creERT2</sup> allele is required.</p><p>Using the <italic>Jchain</italic><sup>creERT2</sup> allele we performed inclusive genetic timestamping of PCs, independent of the time at which cells were generated, cell cycle status, and localization. We uncovered that the numbers of total PCs in the spleen and bone marrow remained constant for at least 5 months. Notably, within the GFP<sup>+</sup> PC population, the decay in numbers of genetically labeled PCs (GFP<sup>+</sup>RFP<sup>+</sup>) was compensated by that of unlabeled PCs (GFP<sup>+</sup>RFP<sup>neg</sup>), supporting that PC turnover is homeostatically regulated in these tissues. Homeostatic control of mature B cell numbers is widely accepted (<xref ref-type="bibr" rid="bib13">Crowley et al., 2009</xref>). In mature B cells, the expression of a B cell receptor is crucial for cell survival (<xref ref-type="bibr" rid="bib62">Srinivasan et al., 2009</xref>; however, BAFF is the limited resource that defines the boundaries of the biological ‘space’; <xref ref-type="bibr" rid="bib13">Crowley et al., 2009</xref>; <xref ref-type="bibr" rid="bib62">Srinivasan et al., 2009</xref>). On other hand, the regulation of PC numbers remains unclear. PCs express the BCMA receptor that allows the sensing of both BAFF and APRIL, and BCMA deficient mice have reduced PC numbers (<xref ref-type="bibr" rid="bib46">O'Connor et al., 2004</xref>). However, because BCMA is expressed in B cells committed to PC differentiation further studies are required to disentangle formation and maintenance (<xref ref-type="bibr" rid="bib37">Mackay et al., 2003</xref>). The <italic>Jchain</italic><sup>creERT2</sup> allele is therefore ideally suited to tackle these questions. PC homeostatic regulation could also be the reflection of a limited number of niches in a given organ which would then limit the number of PCs (<xref ref-type="bibr" rid="bib23">Höfer et al., 2006</xref>; <xref ref-type="bibr" rid="bib27">Khodadadi et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Lightman et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Lindquist et al., 2019</xref>; <xref ref-type="bibr" rid="bib66">Wilmore and Allman, 2017</xref>).</p><p>In this work, we have not determined if the decay in numbers of genetically labeled PCs (GFP<sup>+</sup>RFP<sup>+</sup>) was the reflection of cell death and/or migration away from the tissue analyzed. A possible strategy to determine the latter would be the use of a photoactivatable fluorescent reporter (<xref ref-type="bibr" rid="bib49">Patterson and Lippincott-Schwartz, 2002</xref>) in combination with the <italic>Jchain</italic><sup>creERT2</sup> allele to label through photoactivation PCs in a specific tissue and investigate their migratory patterns. Knowledge on the mechanisms underlying PC homeostasis and turnover is important as these are directly related to long-term protection from infection, vaccination, and cancer pathogenesis. The <italic>Jchain</italic><sup>creERT2</sup> allele is highly suited to perform these investigations as it allows genetic manipulation of PCs in vivo in their microenvironment, and to retrieve live time-stamped PCs for downstream analysis.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>Mus musculus,</italic> C57BL/6)</td><td><italic>Jchain</italic><sup>creERT2</sup>; <italic>Jchain</italic><sup>tm1(EGFP/cre/ERT2)Wtsi</sup></td><td>Wellcome Trust Sanger Institute (WTSI)</td><td>MGI: 5633773</td><td>The allele was purchased from EMMA mouse repository in agreement with WTSI, mice were rederived at the Francis Crick Institute.</td></tr><tr><td>Antibody</td><td>Anti-mouse Blimp1(host species: rat, clone: 6D3)</td><td>BD Biosciences</td><td>Cat#: 565002</td><td>FACS (1:100)</td></tr><tr><td>Antibody</td><td>Anti-mouse CD16/32 Fc Block (host species: rat, clone: 2.4G2)</td><td>BD Biosciences</td><td>Cat#: 553141</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse CD19 (host species: rat, clone: 1D3)</td><td>BD Biosciences</td><td>Cat#: 563557</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse CD23 (host species: rat, clone: B3B4)</td><td>BD Biosciences</td><td>Cat#: 563986</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse CD38 (host species: rat, clone: 90)</td><td>BD Biosciences</td><td>Cat#: 760361</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse CD95 (host species: hamster, clone: Jo2)</td><td>BD Biosciences</td><td>Cat#: 562633</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse IgG1 (host species: rat, clone: A85-1)</td><td>BD Biosciences</td><td>Cat#: 560089</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse CD138 (host species: rat, clone: 281–2)</td><td>BD Biosciences</td><td>Cat#: 740880</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse B220 (host species: rat, clone: RA3-6B2)</td><td>BioLegend</td><td>Cat#: 103247</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse CD11c (host species: hamster, clone: N418)</td><td>BioLegend</td><td>Cat#: 117333</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse CD19 (host species: rat, clone: 6D5)</td><td>BioLegend</td><td>Cat#: 115543</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse CD21/35 (host species: Rat, clone: 7E9)</td><td>BioLegend</td><td>Cat#: 123421</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse CD43 (host species: rat, clone: 1B11)</td><td>BioLegend</td><td>Cat#: 121223</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse CD86 (host species: rat, clone: GL1)</td><td>BioLegend</td><td>Cat#: 105013</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse BP1 (host species: rat, clone: 6C3)</td><td>Ebioscience</td><td>Cat#: 13–5891</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse CD5 (host species: rat, clone: 53–7.3)</td><td>Ebioscience</td><td>Cat#: 13-0051-82</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse CXCR4 (host species: rat, clone: 2B11)</td><td>Ebioscience</td><td>Cat#: 46-9991-82</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse IgA (host species: rat, clone: 11-44-2)</td><td>Ebioscience</td><td>Cat#: 13–5994</td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>Anti-mouse IgM (host species: rat, clone: <break/>II/41)</td><td>Ebioscience</td><td>Cat#: 25–5790</td><td>FACS (1:300)</td></tr><tr><td>Antibody</td><td>Anti-mouse IRF4 (host species: rat, clone: <break/>3E4)</td><td>Ebioscience</td><td>Cat#: 25-9858-80</td><td>FACS (1:200)</td></tr><tr><td>Commercial assay or kit</td><td>BD Cytofix/CytoPerm Fixation/Permeabilization Kit</td><td>BD Biosciences</td><td>Cat#: 554714</td><td/></tr><tr><td>Commercial assay or kit</td><td>Zombie NIR Fixable Viability Kit</td><td>BioLegend</td><td>Cat#: 423106</td><td>(1:200)</td></tr><tr><td>Commercial assay or kit</td><td>CD43 (Ly-48) MicroBeads, mouse</td><td>Miltenyi Biotec</td><td>Cat#: 130-049-801</td><td/></tr><tr><td>Chemical compound, drug</td><td>(Z) 4-hydroxytamoxifen</td><td>Sigma-Aldrich</td><td>CAS: 68047-06-3</td><td/></tr><tr><td>Chemical compound, drug</td><td>Tamoxifen</td><td>Sigma</td><td>Cat#: T5648-5G</td><td/></tr><tr><td>Chemical compound, drug</td><td>Sunflower seed oil from <italic>Helianthus annuus</italic></td><td>Sigma-Aldrich</td><td>Cat#: S5007-250ml</td><td/></tr><tr><td>Software, algorithm</td><td>FACSDiva software</td><td>BD</td><td>V9.0</td><td/></tr><tr><td>Software, algorithm</td><td>FlowJo</td><td>BD</td><td>V10</td><td/></tr><tr><td>Software, algorithm</td><td>Prism</td><td>GraphPad</td><td>V7, V8</td><td/></tr><tr><td>Other</td><td>Sheep red blood cells (SRBCs)</td><td>TCS Biosciences Ltd</td><td>Cat#: SB054</td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>The <italic>Jchain</italic><sup>creERT2</sup> allele was purchased from EMMA in agreement with the Wellcome Trust Sanger Institute (Jchain targeted allele Wtsi MGI:5633773, genebank <ext-link ext-link-type="uri" xlink:href="https://www.i-dcc.org/imits/targ_rep/alleles/43805/escell-clone-genbank-file">https://www.i-dcc.org/imits/targ_rep/alleles/43805/escell-clone-genbank-file</ext-link>) and mice were rederived at the The Francis Crick Institute. The allele contains a splice acceptor site (SA), an <italic>EGFP-2A-creERT2</italic> expression cassette and a poly-A tail in the intron between exons 1 and 2 under the <italic>Jchain</italic> promoter. In addition, exon 2 is loxP-flanked and the allele also contains a rox-flanked puromycin resistance cassette. These mice were crossed to carry a <italic>Rosa26</italic><sup>lslRFP</sup> cre recombination reporter allele (<italic>R26</italic><sup>lsl.RFP</sup>) allele that expresses a non-toxic tandem-dimer red fluorescent protein upon cre-mediated deletion of a floxed STOP cassette (<xref ref-type="bibr" rid="bib35">Luche et al., 2007</xref>). Mice were maintained on the C57BL/6 background and bred at The Francis Crick Institute biological resources facility under specific pathogen-free conditions. Animal experiments were carried out in accordance with national and institutional guidelines for animal care and were approved by The Francis Crick Institute biological resources facility strategic oversight committee (incorporating the Animal Welfare and Ethical Review Body) and by the Home Office, UK. All animal care and procedures followed guidelines of the UK Home Office according to the Animals (Scientific Procedures) Act 1986 and were approved by Biological Research Facility at the Francis Crick Institute. The age of mice ranged between 15–30 weeks as specified.</p></sec><sec id="s4-2"><title>Immunization and in vivo induction of cre activity</title><p>Mice were injected intravenously with 1 × 10<sup>9</sup> sheep red blood cells (SRBCs, TCS Biosciences Ltd) in PBS. For the induction of cre activity, 4 mg tamoxifen (SIGMA T5648) dissolved in sunflower seed oil were administered by oral gavage to mice once per day for multiple days depending on experimental design.</p></sec><sec id="s4-3"><title>In vitro B cell culture and induction of cre activity</title><p>Splenic cells were harvested, and B cells were isolated using CD43 (Ly-48) MicroBeads, mouse (Miltenyi Biotec). The purity of B cells was determined by flow-cytometry (&gt;95%). B cells were cultured in 96-well round-bottom plates (Falcon) in B cell media (DMEM high glucose/Glutamax from Thermo Fisher Scientific supplemented with 10% fetal bovine serum F7524 from Sigma, 100 U/mL Penicillin, 100 µg/mL Streptomycin from Life Technologies, 10 mM HEPES buffer solution from Life Technologies, 100 µM MEM non-essential amino acids from Thermo Fisher Scientific, 1 mM sodium pyruvate from Life Technologies, and 50 uM β-mercaptoethanol from Sigma) at 1 million/mL concentration (200,000 cells/well) with 10 ug/mL LPS and varied concentrations of (Z) 4-hydroxytamoxifen (Sigma-Aldrich). Analysis was performed using flow-cytometry at 48, 72, or 96 hr of culture.</p></sec><sec id="s4-4"><title>Flow cytometry</title><p>Single cell suspensions were stained with antibodies. We used Zombie NIR Fixable Viability Kit (BioLegend) for live/dead discrimination. For intracellular staining, we fixed cells using the BD CytoFix/Cytoperm (BD Biosciences) kit as per manufacturer instructions. Samples were acquired on a BD LSRFortessa analyzer using FACSDiva software (BD) and analyzed on FlowJo software.</p></sec><sec id="s4-5"><title>Quantification and statistical analysis</title><p>Data were analyzed with unpaired two-tailed Student's <italic>t</italic>-test; a p-value=p ≤ 0.05 was considered significant. Prism (v7 and v8, GraphPad) was used for statistical analysis. A single asterisk (<sup>∗</sup>) in the graphs of figures represents a p-value≤0.05, double asterisks (<sup>∗∗</sup>) a p-value≤0.01, triple asterisks (<sup>∗∗∗</sup>) a p-value≤0.001, quadruple asterisks (<sup>∗∗∗∗</sup>) a p-value≤0.0001, and ‘ns’ stands for not statistically significant (i.e. a p-value&gt;0.05). Nonlinear regression (curve fit) using (v8, GraphPad) was used to calculate half-life (t<sub>1/2</sub>) of the population and followed a one-phase decay model, with no special handling of outliers, robust regression and strict convergence criteria and no weighting with a 1000 maximum number of iterations.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank the members of the Immunity and Cancer laboratory (FCI, London) for critical discussions and review of the manuscript; the FCI BRF and Flow-cytometry platforms for expert advice and technical support. This work was supported by The Francis Crick Institute which receives its core funding from Cancer Research UK (FC001057), the UK Medical Research Council (FC001057), the Wellcome Trust (FC001057) to DPC, by CRUK [C355/A26819], FC AECC [C355/A26819], AIRC [C355/A26819] under the Accelerator Award Program to DPC, and an MRC career development award MR/J008060/1 to DPC.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animal experiments were carried out in accordance with national and institutional guidelines for animal care and were approved by The Francis Crick Institute biological resources facility strategic oversight committee (incorporating the Animal Welfare and Ethical Review Body) and by the Home Office, UK licence number PCE886633. All animal care and procedures followed guidelines of the UK Home Office according to the Animals (Scientific Procedures) Act 1986 and were approved by Biological Research Facility at the Francis Crick Institute.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-59850-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p><p>The following previously published dataset was used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Heng</surname><given-names>TS</given-names></name><name><surname>Painter</surname><given-names>MW</given-names></name><collab>Immunological Genome Project Consortium</collab></person-group><year iso-8601-date="2008">2008</year><data-title>ImmGen ULI RNA-seq data</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE127267">GSE127267</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alugupalli</surname> <given-names>KR</given-names></name><name><surname>Leong</surname> <given-names>JM</given-names></name><name><surname>Woodland</surname> <given-names>RT</given-names></name><name><surname>Muramatsu</surname> <given-names>M</given-names></name><name><surname>Honjo</surname> <given-names>T</given-names></name><name><surname>Gerstein</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>B1b lymphocytes confer T cell-independent long-lasting immunity</article-title><source>Immunity</source><volume>21</volume><fpage>379</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2004.06.019</pub-id><pub-id pub-id-type="pmid">15357949</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anastassiadis</surname> <given-names>K</given-names></name><name><surname>Fu</surname> <given-names>J</given-names></name><name><surname>Patsch</surname> <given-names>C</given-names></name><name><surname>Hu</surname> <given-names>S</given-names></name><name><surname>Weidlich</surname> <given-names>S</given-names></name><name><surname>Duerschke</surname> <given-names>K</given-names></name><name><surname>Buchholz</surname> <given-names>F</given-names></name><name><surname>Edenhofer</surname> <given-names>F</given-names></name><name><surname>Stewart</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Dre recombinase, like cre, is a highly efficient site-specific recombinase in <italic>E. coli</italic>, mammalian cells and mice</article-title><source>Disease Models &amp; Mechanisms</source><volume>2</volume><fpage>508</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1242/dmm.003087</pub-id><pub-id pub-id-type="pmid">19692579</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname> <given-names>J</given-names></name><name><surname>Sjöberg</surname> <given-names>O</given-names></name><name><surname>Möller</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1972">1972</year><article-title>Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides</article-title><source>European Journal of Immunology</source><volume>2</volume><fpage>349</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1002/eji.1830020410</pub-id><pub-id pub-id-type="pmid">4563347</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Ayala</surname> <given-names>MV</given-names></name><name><surname>Bonaud</surname> <given-names>A</given-names></name><name><surname>Bender</surname> <given-names>S</given-names></name><name><surname>Lambert</surname> <given-names>J</given-names></name><name><surname>Lechouane</surname> <given-names>F</given-names></name><name><surname>Carrion</surname> <given-names>C</given-names></name><name><surname>Cogne</surname> <given-names>M</given-names></name><name><surname>Pascal</surname> <given-names>V</given-names></name><name><surname>Sirac</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>New models to study plasma cells in mouse based on the restriction of IgJ expression to antibody secreting cells</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.08.13.249441</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonami</surname> <given-names>RH</given-names></name><name><surname>Wolfle</surname> <given-names>WT</given-names></name><name><surname>Thomas</surname> <given-names>JW</given-names></name><name><surname>Kendall</surname> <given-names>PL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>NFATc2 (NFAT1) assists BCR-mediated anergy in anti-insulin B cells</article-title><source>Molecular Immunology</source><volume>62</volume><fpage>321</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2014.01.003</pub-id><pub-id pub-id-type="pmid">24507801</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boross</surname> <given-names>P</given-names></name><name><surname>Breukel</surname> <given-names>C</given-names></name><name><surname>van Loo</surname> <given-names>PF</given-names></name><name><surname>van der Kaa</surname> <given-names>J</given-names></name><name><surname>Claassens</surname> <given-names>JW</given-names></name><name><surname>Bujard</surname> <given-names>H</given-names></name><name><surname>Schönig</surname> <given-names>K</given-names></name><name><surname>Verbeek</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER <sup>T2</sup> by using the LC-1 locus BAC vector</article-title><source>Genesis</source><volume>47</volume><fpage>729</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1002/dvg.20549</pub-id><pub-id pub-id-type="pmid">19621440</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandtzaeg</surname> <given-names>P</given-names></name><name><surname>Prydz</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins</article-title><source>Nature</source><volume>311</volume><fpage>71</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1038/311071a0</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calado</surname> <given-names>DP</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Srinivasan</surname> <given-names>L</given-names></name><name><surname>Sasaki</surname> <given-names>Y</given-names></name><name><surname>Seagal</surname> <given-names>J</given-names></name><name><surname>Unitt</surname> <given-names>C</given-names></name><name><surname>Rodig</surname> <given-names>S</given-names></name><name><surname>Kutok</surname> <given-names>J</given-names></name><name><surname>Tarakhovsky</surname> <given-names>A</given-names></name><name><surname>Schmidt-Supprian</surname> <given-names>M</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma</article-title><source>Cancer Cell</source><volume>18</volume><fpage>580</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2010.11.024</pub-id><pub-id pub-id-type="pmid">21156282</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casola</surname> <given-names>S</given-names></name><name><surname>Cattoretti</surname> <given-names>G</given-names></name><name><surname>Uyttersprot</surname> <given-names>N</given-names></name><name><surname>Koralov</surname> <given-names>SB</given-names></name><name><surname>Seagal</surname> <given-names>J</given-names></name><name><surname>Segal</surname> <given-names>J</given-names></name><name><surname>Hao</surname> <given-names>Z</given-names></name><name><surname>Waisman</surname> <given-names>A</given-names></name><name><surname>Egert</surname> <given-names>A</given-names></name><name><surname>Ghitza</surname> <given-names>D</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Tracking germinal center B cells expressing germ-line immunoglobulin gamma1 transcripts by conditional gene targeting</article-title><source>PNAS</source><volume>103</volume><fpage>7396</fpage><lpage>7401</lpage><pub-id pub-id-type="doi">10.1073/pnas.0602353103</pub-id><pub-id pub-id-type="pmid">16651521</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname> <given-names>CD</given-names></name><name><surname>Flajnik</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Putting J chain back on the map: how might its expression define plasma cell development?</article-title><source>The Journal of Immunology</source><volume>193</volume><fpage>3248</fpage><lpage>3255</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1400531</pub-id><pub-id pub-id-type="pmid">25240020</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croker</surname> <given-names>BA</given-names></name><name><surname>Metcalf</surname> <given-names>D</given-names></name><name><surname>Robb</surname> <given-names>L</given-names></name><name><surname>Wei</surname> <given-names>W</given-names></name><name><surname>Mifsud</surname> <given-names>S</given-names></name><name><surname>DiRago</surname> <given-names>L</given-names></name><name><surname>Cluse</surname> <given-names>LA</given-names></name><name><surname>Sutherland</surname> <given-names>KD</given-names></name><name><surname>Hartley</surname> <given-names>L</given-names></name><name><surname>Williams</surname> <given-names>E</given-names></name><name><surname>Zhang</surname> <given-names>JG</given-names></name><name><surname>Hilton</surname> <given-names>DJ</given-names></name><name><surname>Nicola</surname> <given-names>NA</given-names></name><name><surname>Alexander</surname> <given-names>WS</given-names></name><name><surname>Roberts</surname> <given-names>AW</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis</article-title><source>Immunity</source><volume>20</volume><fpage>153</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(04)00022-6</pub-id><pub-id pub-id-type="pmid">14975238</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crouch</surname> <given-names>EE</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Takizawa</surname> <given-names>M</given-names></name><name><surname>Fichtner-Feigl</surname> <given-names>S</given-names></name><name><surname>Gourzi</surname> <given-names>P</given-names></name><name><surname>Montaño</surname> <given-names>C</given-names></name><name><surname>Feigenbaum</surname> <given-names>L</given-names></name><name><surname>Wilson</surname> <given-names>P</given-names></name><name><surname>Janz</surname> <given-names>S</given-names></name><name><surname>Papavasiliou</surname> <given-names>FN</given-names></name><name><surname>Casellas</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Regulation of AID expression in the immune response</article-title><source>Journal of Experimental Medicine</source><volume>204</volume><fpage>1145</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.1084/jem.20061952</pub-id><pub-id pub-id-type="pmid">17452520</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crowley</surname> <given-names>JE</given-names></name><name><surname>Stadanlick</surname> <given-names>JE</given-names></name><name><surname>Cambier</surname> <given-names>JC</given-names></name><name><surname>Cancro</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>FcgammaRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation</article-title><source>Blood</source><volume>113</volume><fpage>1464</fpage><lpage>1473</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-02-138651</pub-id><pub-id pub-id-type="pmid">18791164</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Boer</surname> <given-names>J</given-names></name><name><surname>Williams</surname> <given-names>A</given-names></name><name><surname>Skavdis</surname> <given-names>G</given-names></name><name><surname>Harker</surname> <given-names>N</given-names></name><name><surname>Coles</surname> <given-names>M</given-names></name><name><surname>Tolaini</surname> <given-names>M</given-names></name><name><surname>Norton</surname> <given-names>T</given-names></name><name><surname>Williams</surname> <given-names>K</given-names></name><name><surname>Roderick</surname> <given-names>K</given-names></name><name><surname>Potocnik</surname> <given-names>AJ</given-names></name><name><surname>Kioussis</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Transgenic mice with hematopoietic and lymphoid specific expression of cre</article-title><source>European Journal of Immunology</source><volume>33</volume><fpage>314</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1002/immu.200310005</pub-id><pub-id pub-id-type="pmid">12548562</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dogan</surname> <given-names>I</given-names></name><name><surname>Bertocci</surname> <given-names>B</given-names></name><name><surname>Vilmont</surname> <given-names>V</given-names></name><name><surname>Delbos</surname> <given-names>F</given-names></name><name><surname>Mégret</surname> <given-names>J</given-names></name><name><surname>Storck</surname> <given-names>S</given-names></name><name><surname>Reynaud</surname> <given-names>C-A</given-names></name><name><surname>Weill</surname> <given-names>J-C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Multiple layers of B cell memory with different effector functions</article-title><source>Nature Immunology</source><volume>10</volume><fpage>1292</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.1038/ni.1814</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Düber</surname> <given-names>S</given-names></name><name><surname>Hafner</surname> <given-names>M</given-names></name><name><surname>Krey</surname> <given-names>M</given-names></name><name><surname>Lienenklaus</surname> <given-names>S</given-names></name><name><surname>Roy</surname> <given-names>B</given-names></name><name><surname>Hobeika</surname> <given-names>E</given-names></name><name><surname>Reth</surname> <given-names>M</given-names></name><name><surname>Buch</surname> <given-names>T</given-names></name><name><surname>Waisman</surname> <given-names>A</given-names></name><name><surname>Kretschmer</surname> <given-names>K</given-names></name><name><surname>Weiss</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Induction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells</article-title><source>Blood</source><volume>114</volume><fpage>4960</fpage><lpage>4967</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-04-218156</pub-id><pub-id pub-id-type="pmid">19812384</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feil</surname> <given-names>S</given-names></name><name><surname>Valtcheva</surname> <given-names>N</given-names></name><name><surname>Feil</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Inducible cre mice</article-title><source>Methods in Molecular Biology</source><volume>530</volume><fpage>343</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1007/978-1-59745-471-1_18</pub-id><pub-id pub-id-type="pmid">19266339</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georgiades</surname> <given-names>P</given-names></name><name><surname>Ogilvy</surname> <given-names>S</given-names></name><name><surname>Duval</surname> <given-names>H</given-names></name><name><surname>Licence</surname> <given-names>DR</given-names></name><name><surname>Charnock-Jones</surname> <given-names>DS</given-names></name><name><surname>Smith</surname> <given-names>SK</given-names></name><name><surname>Print</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages</article-title><source>Genesis</source><volume>34</volume><fpage>251</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1002/gene.10161</pub-id><pub-id pub-id-type="pmid">12434335</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hargreaves</surname> <given-names>DC</given-names></name><name><surname>Hyman</surname> <given-names>PL</given-names></name><name><surname>Lu</surname> <given-names>TT</given-names></name><name><surname>Ngo</surname> <given-names>VN</given-names></name><name><surname>Bidgol</surname> <given-names>A</given-names></name><name><surname>Suzuki</surname> <given-names>G</given-names></name><name><surname>Zou</surname> <given-names>YR</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name><name><surname>Cyster</surname> <given-names>JG</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A coordinated change in chemokine responsiveness guides plasma cell movements</article-title><source>Journal of Experimental Medicine</source><volume>194</volume><fpage>45</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1084/jem.194.1.45</pub-id><pub-id pub-id-type="pmid">11435471</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heng</surname> <given-names>TS</given-names></name><name><surname>Painter</surname> <given-names>MW</given-names></name><collab>Immunological Genome Project Consortium</collab></person-group><year iso-8601-date="2008">2008</year><article-title>The immunological genome project: networks of gene expression in immune cells</article-title><source>Nature Immunology</source><volume>9</volume><fpage>1091</fpage><lpage>1094</lpage><pub-id pub-id-type="doi">10.1038/ni1008-1091</pub-id><pub-id pub-id-type="pmid">18800157</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname> <given-names>F</given-names></name><name><surname>Lortan</surname> <given-names>JE</given-names></name><name><surname>MacLennan</surname> <given-names>IC</given-names></name><name><surname>Khan</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Distinct short-lived and long-lived antibody-producing cell populations</article-title><source>European Journal of Immunology</source><volume>16</volume><fpage>1297</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1002/eji.1830161018</pub-id><pub-id pub-id-type="pmid">3490389</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobeika</surname> <given-names>E</given-names></name><name><surname>Thiemann</surname> <given-names>S</given-names></name><name><surname>Storch</surname> <given-names>B</given-names></name><name><surname>Jumaa</surname> <given-names>H</given-names></name><name><surname>Nielsen</surname> <given-names>PJ</given-names></name><name><surname>Pelanda</surname> <given-names>R</given-names></name><name><surname>Reth</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Testing gene function early in the B cell lineage in mb1-cre mice</article-title><source>PNAS</source><volume>103</volume><fpage>13789</fpage><lpage>13794</lpage><pub-id pub-id-type="doi">10.1073/pnas.0605944103</pub-id><pub-id pub-id-type="pmid">16940357</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Höfer</surname> <given-names>T</given-names></name><name><surname>Muehlinghaus</surname> <given-names>G</given-names></name><name><surname>Moser</surname> <given-names>K</given-names></name><name><surname>Yoshida</surname> <given-names>T</given-names></name><name><surname>E Mei</surname> <given-names>H</given-names></name><name><surname>Hebel</surname> <given-names>K</given-names></name><name><surname>Hauser</surname> <given-names>A</given-names></name><name><surname>Hoyer</surname> <given-names>B</given-names></name><name><surname>O Luger</surname> <given-names>E</given-names></name><name><surname>Dörner</surname> <given-names>T</given-names></name><name><surname>Manz</surname> <given-names>RA</given-names></name><name><surname>Hiepe</surname> <given-names>F</given-names></name><name><surname>Radbruch</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Adaptation of humoral memory</article-title><source>Immunological Reviews</source><volume>211</volume><fpage>295</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1111/j.0105-2896.2006.00380.x</pub-id><pub-id pub-id-type="pmid">16824136</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname> <given-names>FE</given-names></name><name><surname>Braathen</surname> <given-names>R</given-names></name><name><surname>Brandtzaeg</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Role of J chain in secretory immunoglobulin formation</article-title><source>Scandinavian Journal of Immunology</source><volume>52</volume><fpage>240</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1046/j.1365-3083.2000.00790.x</pub-id><pub-id pub-id-type="pmid">10972899</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname> <given-names>SA</given-names></name><name><surname>Garrett-Sinha</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Blimp1: a conserved transcriptional repressor critical for differentiation of many tissues</article-title><source>Experimental Cell Research</source><volume>315</volume><fpage>1077</fpage><lpage>1084</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2008.11.015</pub-id><pub-id pub-id-type="pmid">19073176</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallies</surname> <given-names>A</given-names></name><name><surname>Hasbold</surname> <given-names>J</given-names></name><name><surname>Fairfax</surname> <given-names>K</given-names></name><name><surname>Pridans</surname> <given-names>C</given-names></name><name><surname>Emslie</surname> <given-names>D</given-names></name><name><surname>McKenzie</surname> <given-names>BS</given-names></name><name><surname>Lew</surname> <given-names>AM</given-names></name><name><surname>Corcoran</surname> <given-names>LM</given-names></name><name><surname>Hodgkin</surname> <given-names>PD</given-names></name><name><surname>Tarlinton</surname> <given-names>DM</given-names></name><name><surname>Nutt</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1</article-title><source>Immunity</source><volume>26</volume><fpage>555</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.04.007</pub-id><pub-id pub-id-type="pmid">17509907</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khodadadi</surname> <given-names>L</given-names></name><name><surname>Cheng</surname> <given-names>Q</given-names></name><name><surname>Radbruch</surname> <given-names>A</given-names></name><name><surname>Hiepe</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The maintenance of memory plasma cells</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>721</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.00721</pub-id><pub-id pub-id-type="pmid">31024553</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname> <given-names>U</given-names></name><name><surname>Casola</surname> <given-names>S</given-names></name><name><surname>Cattoretti</surname> <given-names>G</given-names></name><name><surname>Shen</surname> <given-names>Q</given-names></name><name><surname>Lia</surname> <given-names>M</given-names></name><name><surname>Mo</surname> <given-names>T</given-names></name><name><surname>Ludwig</surname> <given-names>T</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name><name><surname>Dalla-Favera</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination</article-title><source>Nature Immunology</source><volume>7</volume><fpage>773</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1038/ni1357</pub-id><pub-id pub-id-type="pmid">16767092</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koscielny</surname> <given-names>G</given-names></name><name><surname>Yaikhom</surname> <given-names>G</given-names></name><name><surname>Iyer</surname> <given-names>V</given-names></name><name><surname>Meehan</surname> <given-names>TF</given-names></name><name><surname>Morgan</surname> <given-names>H</given-names></name><name><surname>Atienza-Herrero</surname> <given-names>J</given-names></name><name><surname>Blake</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>CK</given-names></name><name><surname>Easty</surname> <given-names>R</given-names></name><name><surname>Di Fenza</surname> <given-names>A</given-names></name><name><surname>Fiegel</surname> <given-names>T</given-names></name><name><surname>Grifiths</surname> <given-names>M</given-names></name><name><surname>Horne</surname> <given-names>A</given-names></name><name><surname>Karp</surname> <given-names>NA</given-names></name><name><surname>Kurbatova</surname> <given-names>N</given-names></name><name><surname>Mason</surname> <given-names>JC</given-names></name><name><surname>Matthews</surname> <given-names>P</given-names></name><name><surname>Oakley</surname> <given-names>DJ</given-names></name><name><surname>Qazi</surname> <given-names>A</given-names></name><name><surname>Regnart</surname> <given-names>J</given-names></name><name><surname>Retha</surname> <given-names>A</given-names></name><name><surname>Santos</surname> <given-names>LA</given-names></name><name><surname>Sneddon</surname> <given-names>DJ</given-names></name><name><surname>Warren</surname> <given-names>J</given-names></name><name><surname>Westerberg</surname> <given-names>H</given-names></name><name><surname>Wilson</surname> <given-names>RJ</given-names></name><name><surname>Melvin</surname> <given-names>DG</given-names></name><name><surname>Smedley</surname> <given-names>D</given-names></name><name><surname>Brown</surname> <given-names>SD</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name><name><surname>Skarnes</surname> <given-names>WC</given-names></name><name><surname>Mallon</surname> <given-names>AM</given-names></name><name><surname>Parkinson</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The international mouse phenotyping consortium web portal, a unified point of access for knockout mice and related phenotyping data</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>D802</fpage><lpage>D809</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt977</pub-id><pub-id pub-id-type="pmid">24194600</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraus</surname> <given-names>M</given-names></name><name><surname>Alimzhanov</surname> <given-names>MB</given-names></name><name><surname>Rajewsky</surname> <given-names>N</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Survival of resting mature B lymphocytes depends on BCR signaling via the igalpha/beta heterodimer</article-title><source>Cell</source><volume>117</volume><fpage>787</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.05.014</pub-id><pub-id pub-id-type="pmid">15186779</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname> <given-names>K</given-names></name><name><surname>Hutter</surname> <given-names>C</given-names></name><name><surname>Sun</surname> <given-names>Q</given-names></name><name><surname>Bilic</surname> <given-names>I</given-names></name><name><surname>Cobaleda</surname> <given-names>C</given-names></name><name><surname>Malin</surname> <given-names>S</given-names></name><name><surname>Busslinger</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development</article-title><source>Immunity</source><volume>28</volume><fpage>751</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.04.014</pub-id><pub-id pub-id-type="pmid">18538592</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemke</surname> <given-names>A</given-names></name><name><surname>Kraft</surname> <given-names>M</given-names></name><name><surname>Roth</surname> <given-names>K</given-names></name><name><surname>Riedel</surname> <given-names>R</given-names></name><name><surname>Lammerding</surname> <given-names>D</given-names></name><name><surname>Hauser</surname> <given-names>AE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Long-lived plasma cells are generated in mucosal immune responses and contribute to the bone marrow plasma cell pool in mice</article-title><source>Mucosal Immunology</source><volume>9</volume><fpage>83</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1038/mi.2015.38</pub-id><pub-id pub-id-type="pmid">25943272</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lightman</surname> <given-names>SM</given-names></name><name><surname>Utley</surname> <given-names>A</given-names></name><name><surname>Lee</surname> <given-names>KP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Survival of Long-Lived plasma cells (LLPC): Piecing together the puzzle</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>965</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.00965</pub-id><pub-id pub-id-type="pmid">31130955</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindquist</surname> <given-names>RL</given-names></name><name><surname>Niesner</surname> <given-names>RA</given-names></name><name><surname>Hauser</surname> <given-names>AE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>In the right place, at the right time: spatiotemporal conditions determining plasma cell survival and function</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>788</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.00788</pub-id><pub-id pub-id-type="pmid">31068930</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luche</surname> <given-names>H</given-names></name><name><surname>Weber</surname> <given-names>O</given-names></name><name><surname>Nageswara Rao</surname> <given-names>T</given-names></name><name><surname>Blum</surname> <given-names>C</given-names></name><name><surname>Fehling</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Faithful activation of an extra-bright red fluorescent protein in &quot;knock-in&quot; Cre-reporter mice ideally suited for lineage tracing studies</article-title><source>European Journal of Immunology</source><volume>37</volume><fpage>43</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1002/eji.200636745</pub-id><pub-id pub-id-type="pmid">17171761</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lycke</surname> <given-names>N</given-names></name><name><surname>Erlandsson</surname> <given-names>L</given-names></name><name><surname>Ekman</surname> <given-names>L</given-names></name><name><surname>Schön</surname> <given-names>K</given-names></name><name><surname>Leanderson</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection</article-title><source>Journal of Immunology</source><volume>163</volume><fpage>913</fpage><lpage>919</lpage><pub-id pub-id-type="pmid">10395687</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname> <given-names>F</given-names></name><name><surname>Schneider</surname> <given-names>P</given-names></name><name><surname>Rennert</surname> <given-names>P</given-names></name><name><surname>Browning</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>BAFF AND APRIL: a tutorial on B cell survival</article-title><source>Annual Review of Immunology</source><volume>21</volume><fpage>231</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.21.120601.141152</pub-id><pub-id pub-id-type="pmid">12427767</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manz</surname> <given-names>RA</given-names></name><name><surname>Thiel</surname> <given-names>A</given-names></name><name><surname>Radbruch</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Lifetime of plasma cells in the bone marrow</article-title><source>Nature</source><volume>388</volume><fpage>133</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1038/40540</pub-id><pub-id pub-id-type="pmid">9217150</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manz</surname> <given-names>RA</given-names></name><name><surname>Löhning</surname> <given-names>M</given-names></name><name><surname>Cassese</surname> <given-names>G</given-names></name><name><surname>Thiel</surname> <given-names>A</given-names></name><name><surname>Radbruch</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Survival of long-lived plasma cells is independent of antigen</article-title><source>International Immunology</source><volume>10</volume><fpage>1703</fpage><lpage>1711</lpage><pub-id pub-id-type="doi">10.1093/intimm/10.11.1703</pub-id><pub-id pub-id-type="pmid">9846699</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mather</surname> <given-names>EL</given-names></name><name><surname>Alt</surname> <given-names>FW</given-names></name><name><surname>Bothwell</surname> <given-names>AL</given-names></name><name><surname>Baltimore</surname> <given-names>D</given-names></name><name><surname>Koshland</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Expression of J chain RNA in cell lines representing different stages of B lymphocyte differentiation</article-title><source>Cell</source><volume>23</volume><fpage>369</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(81)90132-X</pub-id><pub-id pub-id-type="pmid">6781757</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Max</surname> <given-names>EE</given-names></name><name><surname>Korsmeyer</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Human J chain gene. structure and expression in B lymphoid cells</article-title><source>Journal of Experimental Medicine</source><volume>161</volume><fpage>832</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1084/jem.161.4.832</pub-id><pub-id pub-id-type="pmid">2984306</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyers</surname> <given-names>EN</given-names></name><name><surname>Lewandoski</surname> <given-names>M</given-names></name><name><surname>Martin</surname> <given-names>GR</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>An Fgf8 mutant allelic series generated by cre- and Flp-mediated recombination</article-title><source>Nature Genetics</source><volume>18</volume><fpage>136</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1038/ng0298-136</pub-id><pub-id pub-id-type="pmid">9462741</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriyama</surname> <given-names>S</given-names></name><name><surname>Takahashi</surname> <given-names>N</given-names></name><name><surname>Green</surname> <given-names>JA</given-names></name><name><surname>Hori</surname> <given-names>S</given-names></name><name><surname>Kubo</surname> <given-names>M</given-names></name><name><surname>Cyster</surname> <given-names>JG</given-names></name><name><surname>Okada</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sphingosine-1-phosphate receptor 2 is critical for follicular helper T cell retention in germinal centers</article-title><source>Journal of Experimental Medicine</source><volume>211</volume><fpage>1297</fpage><lpage>1305</lpage><pub-id pub-id-type="doi">10.1084/jem.20131666</pub-id><pub-id pub-id-type="pmid">24913235</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname> <given-names>A</given-names></name><name><surname>Moens</surname> <given-names>C</given-names></name><name><surname>Ivanyi</surname> <given-names>E</given-names></name><name><surname>Pawling</surname> <given-names>J</given-names></name><name><surname>Gertsenstein</surname> <given-names>M</given-names></name><name><surname>Hadjantonakis</surname> <given-names>AK</given-names></name><name><surname>Pirity</surname> <given-names>M</given-names></name><name><surname>Rossant</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles</article-title><source>Current Biology</source><volume>8</volume><fpage>661</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(98)70254-4</pub-id><pub-id pub-id-type="pmid">9635194</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nutt</surname> <given-names>SL</given-names></name><name><surname>Hodgkin</surname> <given-names>PD</given-names></name><name><surname>Tarlinton</surname> <given-names>DM</given-names></name><name><surname>Corcoran</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The generation of antibody-secreting plasma cells</article-title><source>Nature Reviews Immunology</source><volume>15</volume><fpage>160</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1038/nri3795</pub-id><pub-id pub-id-type="pmid">25698678</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Connor</surname> <given-names>BP</given-names></name><name><surname>Raman</surname> <given-names>VS</given-names></name><name><surname>Erickson</surname> <given-names>LD</given-names></name><name><surname>Cook</surname> <given-names>WJ</given-names></name><name><surname>Weaver</surname> <given-names>LK</given-names></name><name><surname>Ahonen</surname> <given-names>C</given-names></name><name><surname>Lin</surname> <given-names>LL</given-names></name><name><surname>Mantchev</surname> <given-names>GT</given-names></name><name><surname>Bram</surname> <given-names>RJ</given-names></name><name><surname>Noelle</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>BCMA is essential for the survival of long-lived bone marrow plasma cells</article-title><source>Journal of Experimental Medicine</source><volume>199</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1084/jem.20031330</pub-id><pub-id pub-id-type="pmid">14707116</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohinata</surname> <given-names>Y</given-names></name><name><surname>Payer</surname> <given-names>B</given-names></name><name><surname>O'Carroll</surname> <given-names>D</given-names></name><name><surname>Ancelin</surname> <given-names>K</given-names></name><name><surname>Ono</surname> <given-names>Y</given-names></name><name><surname>Sano</surname> <given-names>M</given-names></name><name><surname>Barton</surname> <given-names>SC</given-names></name><name><surname>Obukhanych</surname> <given-names>T</given-names></name><name><surname>Nussenzweig</surname> <given-names>M</given-names></name><name><surname>Tarakhovsky</surname> <given-names>A</given-names></name><name><surname>Saitou</surname> <given-names>M</given-names></name><name><surname>Surani</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Blimp1 is a critical determinant of the germ cell lineage in mice</article-title><source>Nature</source><volume>436</volume><fpage>207</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1038/nature03813</pub-id><pub-id pub-id-type="pmid">15937476</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palumbo</surname> <given-names>A</given-names></name><name><surname>Anderson</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Multiple myeloma</article-title><source>New England Journal of Medicine</source><volume>364</volume><fpage>1046</fpage><lpage>1060</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1011442</pub-id><pub-id pub-id-type="pmid">21410373</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname> <given-names>GH</given-names></name><name><surname>Lippincott-Schwartz</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A photoactivatable GFP for selective photolabeling of proteins and cells</article-title><source>Science</source><volume>297</volume><fpage>1873</fpage><lpage>1877</lpage><pub-id pub-id-type="doi">10.1126/science.1074952</pub-id><pub-id pub-id-type="pmid">12228718</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pracht</surname> <given-names>K</given-names></name><name><surname>Meinzinger</surname> <given-names>J</given-names></name><name><surname>Daum</surname> <given-names>P</given-names></name><name><surname>Schulz</surname> <given-names>SR</given-names></name><name><surname>Reimer</surname> <given-names>D</given-names></name><name><surname>Hauke</surname> <given-names>M</given-names></name><name><surname>Roth</surname> <given-names>E</given-names></name><name><surname>Mielenz</surname> <given-names>D</given-names></name><name><surname>Berek</surname> <given-names>C</given-names></name><name><surname>Côrte-Real</surname> <given-names>J</given-names></name><name><surname>Jäck</surname> <given-names>HM</given-names></name><name><surname>Schuh</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A new staining protocol for detection of murine antibody-secreting plasma cell subsets by flow cytometry</article-title><source>European Journal of Immunology</source><volume>47</volume><fpage>1389</fpage><lpage>1392</lpage><pub-id pub-id-type="doi">10.1002/eji.201747019</pub-id><pub-id pub-id-type="pmid">28608550</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rickert</surname> <given-names>RC</given-names></name><name><surname>Roes</surname> <given-names>J</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>B lymphocyte-specific, Cre-mediated mutagenesis in mice</article-title><source>Nucleic Acids Research</source><volume>25</volume><fpage>1317</fpage><lpage>1318</lpage><pub-id pub-id-type="doi">10.1093/nar/25.6.1317</pub-id><pub-id pub-id-type="pmid">9092650</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinkenberger</surname> <given-names>JL</given-names></name><name><surname>Wallin</surname> <given-names>JJ</given-names></name><name><surname>Johnson</surname> <given-names>KW</given-names></name><name><surname>Koshland</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>An Interleukin-2 signal relieves BSAP (Pax5)-Mediated repression of the immunoglobulin J chain gene</article-title><source>Immunity</source><volume>5</volume><fpage>377</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/s1074-7613(00)80263-0</pub-id><pub-id pub-id-type="pmid">8885870</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robbiani</surname> <given-names>DF</given-names></name><name><surname>Bothmer</surname> <given-names>A</given-names></name><name><surname>Callen</surname> <given-names>E</given-names></name><name><surname>Reina-San-Martin</surname> <given-names>B</given-names></name><name><surname>Dorsett</surname> <given-names>Y</given-names></name><name><surname>Difilippantonio</surname> <given-names>S</given-names></name><name><surname>Bolland</surname> <given-names>DJ</given-names></name><name><surname>Chen</surname> <given-names>HT</given-names></name><name><surname>Corcoran</surname> <given-names>AE</given-names></name><name><surname>Nussenzweig</surname> <given-names>A</given-names></name><name><surname>Nussenzweig</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations</article-title><source>Cell</source><volume>135</volume><fpage>1028</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.09.062</pub-id><pub-id pub-id-type="pmid">19070574</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweighoffer</surname> <given-names>E</given-names></name><name><surname>Vanes</surname> <given-names>L</given-names></name><name><surname>Nys</surname> <given-names>J</given-names></name><name><surname>Cantrell</surname> <given-names>D</given-names></name><name><surname>McCleary</surname> <given-names>S</given-names></name><name><surname>Smithers</surname> <given-names>N</given-names></name><name><surname>Tybulewicz</surname> <given-names>VL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway</article-title><source>Immunity</source><volume>38</volume><fpage>475</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.11.015</pub-id><pub-id pub-id-type="pmid">23453634</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sciammas</surname> <given-names>R</given-names></name><name><surname>Shaffer</surname> <given-names>AL</given-names></name><name><surname>Schatz</surname> <given-names>JH</given-names></name><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Staudt</surname> <given-names>LM</given-names></name><name><surname>Singh</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation</article-title><source>Immunity</source><volume>25</volume><fpage>225</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2006.07.009</pub-id><pub-id pub-id-type="pmid">16919487</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaffer</surname> <given-names>AL</given-names></name><name><surname>Shapiro-Shelef</surname> <given-names>M</given-names></name><name><surname>Iwakoshi</surname> <given-names>NN</given-names></name><name><surname>Lee</surname> <given-names>AH</given-names></name><name><surname>Qian</surname> <given-names>SB</given-names></name><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Yu</surname> <given-names>X</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Tan</surname> <given-names>BK</given-names></name><name><surname>Rosenwald</surname> <given-names>A</given-names></name><name><surname>Hurt</surname> <given-names>EM</given-names></name><name><surname>Petroulakis</surname> <given-names>E</given-names></name><name><surname>Sonenberg</surname> <given-names>N</given-names></name><name><surname>Yewdell</surname> <given-names>JW</given-names></name><name><surname>Calame</surname> <given-names>K</given-names></name><name><surname>Glimcher</surname> <given-names>LH</given-names></name><name><surname>Staudt</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation</article-title><source>Immunity</source><volume>21</volume><fpage>81</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2004.06.010</pub-id><pub-id pub-id-type="pmid">15345222</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Shapiro</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="1995">1995</year><source>Practical Flow Cytometry</source><publisher-loc>New York</publisher-loc><publisher-name>John Wiley and Sons, Inc</publisher-name><pub-id pub-id-type="doi">10.1002/0471722731</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro-Shelef</surname> <given-names>M</given-names></name><name><surname>Lin</surname> <given-names>KI</given-names></name><name><surname>McHeyzer-Williams</surname> <given-names>LJ</given-names></name><name><surname>Liao</surname> <given-names>J</given-names></name><name><surname>McHeyzer-Williams</surname> <given-names>MG</given-names></name><name><surname>Calame</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells</article-title><source>Immunity</source><volume>19</volume><fpage>607</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(03)00267-X</pub-id><pub-id pub-id-type="pmid">14563324</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shilova</surname> <given-names>ON</given-names></name><name><surname>Shilov</surname> <given-names>ES</given-names></name><name><surname>Deyev</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The effect of trypan blue treatment on autofluorescence of fixed cells</article-title><source>Cytometry Part A</source><volume>91</volume><fpage>917</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1002/cyto.a.23199</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinnakasu</surname> <given-names>R</given-names></name><name><surname>Inoue</surname> <given-names>T</given-names></name><name><surname>Kometani</surname> <given-names>K</given-names></name><name><surname>Moriyama</surname> <given-names>S</given-names></name><name><surname>Adachi</surname> <given-names>Y</given-names></name><name><surname>Nakayama</surname> <given-names>M</given-names></name><name><surname>Takahashi</surname> <given-names>Y</given-names></name><name><surname>Fukuyama</surname> <given-names>H</given-names></name><name><surname>Okada</surname> <given-names>T</given-names></name><name><surname>Kurosaki</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Regulated selection of germinal-center cells into the memory B cell compartment</article-title><source>Nature Immunology</source><volume>17</volume><fpage>861</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1038/ni.3460</pub-id><pub-id pub-id-type="pmid">27158841</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slifka</surname> <given-names>MK</given-names></name><name><surname>Antia</surname> <given-names>R</given-names></name><name><surname>Whitmire</surname> <given-names>JK</given-names></name><name><surname>Ahmed</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Humoral immunity due to long-lived plasma cells</article-title><source>Immunity</source><volume>8</volume><fpage>363</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80541-5</pub-id><pub-id pub-id-type="pmid">9529153</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname> <given-names>L</given-names></name><name><surname>Sasaki</surname> <given-names>Y</given-names></name><name><surname>Calado</surname> <given-names>DP</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Paik</surname> <given-names>JH</given-names></name><name><surname>DePinho</surname> <given-names>RA</given-names></name><name><surname>Kutok</surname> <given-names>JL</given-names></name><name><surname>Kearney</surname> <given-names>JF</given-names></name><name><surname>Otipoby</surname> <given-names>KL</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>PI3 kinase signals BCR-Dependent mature B cell survival</article-title><source>Cell</source><volume>139</volume><fpage>573</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.08.041</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sze</surname> <given-names>DM</given-names></name><name><surname>Toellner</surname> <given-names>KM</given-names></name><name><surname>García de Vinuesa</surname> <given-names>C</given-names></name><name><surname>Taylor</surname> <given-names>DR</given-names></name><name><surname>MacLennan</surname> <given-names>IC</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival</article-title><source>The Journal of Experimental Medicine</source><volume>192</volume><fpage>813</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1084/jem.192.6.813</pub-id><pub-id pub-id-type="pmid">10993912</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szymczak</surname> <given-names>AL</given-names></name><name><surname>Workman</surname> <given-names>CJ</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Vignali</surname> <given-names>KM</given-names></name><name><surname>Dilioglou</surname> <given-names>S</given-names></name><name><surname>Vanin</surname> <given-names>EF</given-names></name><name><surname>Vignali</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector</article-title><source>Nature Biotechnology</source><volume>22</volume><fpage>589</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1038/nbt957</pub-id><pub-id pub-id-type="pmid">15064769</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname> <given-names>T</given-names></name><name><surname>Seagal</surname> <given-names>J</given-names></name><name><surname>Winkler</surname> <given-names>W</given-names></name><name><surname>Wirtz</surname> <given-names>T</given-names></name><name><surname>Chu</surname> <given-names>VT</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A novel allele for inducible cre expression in germinal center B cells</article-title><source>European Journal of Immunology</source><volume>49</volume><fpage>192</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1002/eji.201847863</pub-id><pub-id pub-id-type="pmid">30359469</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilmore</surname> <given-names>JR</given-names></name><name><surname>Allman</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Here, there, and anywhere? arguments for and against the physical plasma cell survival niche</article-title><source>The Journal of Immunology</source><volume>199</volume><fpage>839</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1700461</pub-id><pub-id pub-id-type="pmid">28739594</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Yasuda</surname> <given-names>T</given-names></name><name><surname>Wirtz</surname> <given-names>T</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Wunderlich</surname> <given-names>T</given-names></name><name><surname>Schmidt-Supprian</surname> <given-names>M</given-names></name><name><surname>Sommermann</surname> <given-names>T</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Studying Epstein-Barr virus pathologies and immune surveillance by reconstructing EBV infection in mice</article-title><conf-name>Cold Spring Harbor Symposia on Quantitative Biology</conf-name><fpage>259</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1101/sqb.2013.78.020222</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.59850.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Sen</surname><given-names>Ranjan</given-names></name><role>Reviewing Editor</role><aff><institution>National Institute on Aging</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>The generation and analysis of <italic>Jchain</italic><sup>creERT2</sup> tool described in this manuscript will be a valuable addition to the arsenal of regulatable Cre transgenes available to probe the immune system. Your studies have already provided new insights into plasma cell homeostasis that will stage for the use of this mouse strain for additional analyses. We wish you continued success in probing the biology of plasma cells via development and use of novel reagents such as the one described in this manuscript.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Genetic timestamping of plasma cells in vivo reveals homeostatic population turnover&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Satyajit Rath as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p><p>Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in <italic>eLife</italic>, either of which would be linked to the original paper.</p><p>Summary:</p><p>Both reviewers found this work to be important and characterization of the use of <italic>Jchain</italic><sup>creERT2</sup> mice as a valuable resource for inducible manipulation of genes in plasma cells (PC). The reviewers noted that &quot;The present manuscript presents experiments that convincingly demonstrate the suitability of a <italic>Jchain</italic><sup>creERT2</sup> mice (inducible Cre) to delete loxP-flanked genes specifically in the plasma cell (PC) lineage in an inducible fashion&quot; and the work &quot;addresses an important question in plasma cell biology by developing a genetic time-stamping in vivo tool to look at plasma cell turnover&quot;. However, both reviewers raised points enumerated below that need to be addressed before further consideration of this manuscript for publication.</p><p>Essential revisions:</p><p>1) Account for the presence of GFP<sup>lo</sup>B220<sup>hi</sup> cells that appear to be present in control mice as well. Do these represent non-specific staining? If so, how can the contribution of GFP from the modified J chain allele be distinguished from the background? This question is pertinent to Figures 1C, 2C and 3B and could be resolved by providing staining in the GFP<sup>lo</sup>B220<sup>hi</sup> gate for CD138, CXCR4, Blimp1 and IRF4.</p><p>2) Clarify the basis of the conclusion that the &quot;…analysis did not support the concept that the J chain is expressed by all PCs&quot;.</p><p>3) Modify the fourth paragraph of the Discussion, there is sentence in the middle which appears to have some missing words.</p><p>4) Quote the plasma cell paper from Singh/Staudt labs ion the role of IRF4 (Sciammas et al., 2006).</p><p>5) Justify the interpretation critical for the analysis of homeostatic turnover of PC that decline in RFP<sup>+</sup> cells is due to loss of PC rather than other possibilities such as migration of PCs to other niches. While this would ideally involve additional experiments with BrdU-labeled cells, a strong rationale for their interpretation along with a succinct discussion of possible limitations in their analysis would suffice for reconsideration of the manuscript.</p><p>6) As an extension to the above point, were RFP<sup>+</sup> cells scored in other PC survival niches?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.59850.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Account for the presence of GFP<sup>lo</sup>B220<sup>hi</sup> cells that appear to be present in control mice as well. Do these represent non-specific staining? If so, how can the contribution of GFP from the modified J chain allele be distinguished from the background? This question is pertinent to Figures 1C, 2C and 3B and could be resolved by providing staining in the GFP<sup>lo</sup>B220<sup>hi</sup> gate for CD138, CXCR4, Blimp1 and IRF4.</p></disp-quote><p>This is valid comment. We defined the GFP<sup>low</sup>B220<sup>hi</sup> gate in order to not disregard the occurrence of cells with a low-level of GFP expression in mice carrying the <italic>Jchain-cre<sup>ERT2</sup></italic> allele. However, as the reviewer’s point out this led to the inclusion of a small fraction of false GFP positive cells as indicated by the analysis of control mice (wild-type C57BL/6) that are GFP negative. Following the reviewer’s comment, we analyzed data to quantify the contribution of GFP from the <italic>Jchain-cre<sup>ERT2</sup></italic> allele within the GFP<sup>low</sup>B220<sup>hi</sup> gate. We found that the fraction of cells within the GFP<sup>lo</sup>B220<sup>hi</sup> gate was significantly increased in mice carrying the <italic>Jchain-cre<sup>ERT2</sup></italic> allele (Figure 2—figure supplement 1A). The cells within the GFP<sup>low</sup>B220<sup>hi</sup> gate of mice carrying the <italic>Jchain-cre<sup>ERT2</sup></italic> allele were enriched for B cells (CD138<sup>neg</sup>B220<sup>hi</sup>CD19<sup>+</sup>) compared to control mice and these B cells mostly represented germinal center B cells (Figure 2—figure supplement 1B) in agreement to the data presented in Figure 2F and G of the manuscript. Thus, although the GFP<sup>low</sup>B220<sup>hi</sup> gate includes 0 to 0.16% of GFP negative cells as determined in control mice, it provides a significant enrichment for GFP<sup>low</sup> cells in mice carrying the <italic>Jchain-cre<sup>ERT2</sup></italic> allele.</p><p>With respect to CD138<sup>+</sup>, CD138<sup>+</sup>CXCR4<sup>+</sup> and BLIMP1<sup>+</sup>IRF4<sup>+</sup> cells within the GFP<sup>low</sup>B220<sup>hi</sup> population, these were enriched in a fraction of mice carrying the <italic>Jchain-cre<sup>ERT2</sup></italic> allele, approximately 30%, compared to control mice (Figure 2—figure supplement 1C-D). However, for 70% of mice carrying the <italic>Jchain-cre<sup>ERT2</sup></italic> allele the GFP<sup>low</sup>B220<sup>hi</sup> population was not enriched for cells with these markers compared to control background.</p><p>In summary, whereas the experimental analysis of the GFP<sup>low</sup>B220<sup>hi</sup> gate determines the enrichment for cells expressing a low-level GFP in mice carrying the <italic>Jchain-cre<sup>ERT2</sup></italic> allele, representing mostly germinal center B cells, caution should be taken when using this gating strategy to study enrichment for cells with plasma cell markers, as this gate may contain an unacceptable level of contamination by non-GFP positive cells. If the underlying reason for the false GFP positivity within the GFP<sup>low</sup>B220<sup>hi</sup> population is autofluorescence; a common issue when GFP is weakly expressed because autofluorescence typically displays similar excitation and emission characteristics to GFP (Shapiro, 1995); approaches that quench autofluorescence may reduce or abrogate background (Shilova et al., 2017). Alternatively, the experimenter may design a more stringent gate, possibly increasing specificity and thus reducing contamination as long as the loss of a fraction of lowly expressing GFP cells is acceptable and consideration is taken into account that such stringency could also introduce bias in the analysis.</p><p>We have included this data as a Figure 2—figure supplement 1 and Figure 3—figure supplement 1 and present and discuss the data in the Results and Discussion sections.</p><disp-quote content-type="editor-comment"><p>2) Clarify the basis of the conclusion that the &quot;…analysis did not support the concept that the J chain is expressed by all PCs&quot;.</p></disp-quote><p>Following the reviewer’s comment we considered that this conclusion is not accurate. The analysis of mice carrying the <italic>Jchain-cre<sup>ERT2</sup></italic> allele revealed that roughly 60-90% of CD138<sup>+</sup>CXCR4<sup>+</sup> cells express GFP (Figure 2—figure supplement 2). As GFP expression is driven by the endogenous <italic>Jchain</italic> promoter this data may suggest in a first approximation that a minor fraction of plasma cells does not express JCHAIN. However, there are inherent limitations of using GFP as a reporter as it does not directly measure JCHAIN itself at the transcriptional and translational level.</p><p>We have corrected our statement and added these considerations in the manuscript: Discussion section, fifth paragraph.</p><disp-quote content-type="editor-comment"><p>3) Modify the fourth paragraph of the Discussion, there is sentence in the middle 12 which appears to have some missing words.</p></disp-quote><p>We thank the reviewers for highlighting that correction is needed for this sentence. We now wrote in Discussion section: “Thus, inadvertent or intentional removal of the puromycin selection cassette may increase cre<sup>ERT2</sup> expression, including in B cells, possibly reducing the PC specificity of <italic>Jchain<sup>creERT2</sup></italic> mediated genetic manipulation.”.</p><disp-quote content-type="editor-comment"><p>4) Quote the plasma cell paper from Singh/Staudt labs ion the role of IRF4 (Sciammas et al., 2006).</p></disp-quote><p>We apologize for this omission. The reference as now been added when introducing IRF4 in the first paragraph of the Introduction, and in the first paragraph of the Results subsection “<italic>Jchain</italic> expression correlates with that of IRF4 and BLIMP1”, where the analysis of IRF4 is described.</p><disp-quote content-type="editor-comment"><p>5) Justify the interpretation critical for the analysis of homeostatic turnover of PC that decline in RFP<sup>+</sup> cells is due to loss of PC rather than other possibilities such as migration of PCs to other niches. While this would ideally involve additional experiments with BrdU-labeled cells, a strong rationale for their interpretation along with a succinct discussion of possible limitations in their analysis would suffice for reconsideration of the manuscript.</p></disp-quote><p>This is a relevant comment. We agree that the cell number turnover of labelled RFP<sup>+</sup> could be at least in part due to the migration of cells out of the tissues analyzed. Thus, to be clear, we agree that the data presented in the manuscript does not address if the decay in RFP<sup>+</sup> plasma cell numbers is due to cell death and/or migration.</p><p>We were, however, struck by the observation that the absolute number of total plasma cells in spleen and bone marrow remained largely unaltered over time (5 month of analysis), suggesting that the number of plasma cells is homeostatically regulated in those tissues. This observation in addition to the finding that the loss in cell numbers of RFP<sup>+</sup>GFP<sup>+</sup> plasma cells over-time was “compensated” by increased cell numbers of RFP<sup>neg</sup>GFP<sup>+</sup> plasma cells, supported homeostatic population turnover in the tissues analyzed. As mentioned above it remains to be determined whether the turnover of RFP<sup>+</sup>GFP<sup>+</sup> plasma cells is due to cell death and/or cell migration. It is also not possible to formulate at this stage a conclusion at the organism level, that would require an in-depth analysis of multiple tissues of the body.</p><p>To reflect these considerations, we included in the title of the manuscript the term “tissue-specific” and modified the text of the manuscript highlighting the limitations of the analysis: Discussion section, last paragraph.</p><p>We have considered the proposition to perform BrdU cell labelling to address the question whether cell migration occurs between tissues. BrdU labelling would indeed allow the identification of nascent plasma cells generated in secondary lymphoid organs namely spleen, lymph nodes and gut associated lymphoid tissue, the major sites of B-to-plasma cell differentiation. This would permit the investigation of the migration of nascent RFP<sup>+</sup> plasma cells into the bone marrow and other sites where plasma cells are not thought to be formed. However, the calculation of the re-circulation of bone marrow RFP<sup>+</sup>BrdU<sup>+</sup> plasma cells into secondary lymphoid organs would likely be confounded by the presence of RFP<sup>+</sup> plasma cells labelled with BrdU in situ or derived from other tissues. The follow up of the migration of already formed quiescent RFP<sup>+</sup>BrdU<sup>neg</sup> plasma cells at the time of BrdU labelling would not be possible.</p><p>A possible strategy to overcome these limitations would be the use of a photoactivatable fluorescent reporter in combination with the <italic>Jchain-cre<sup>ERT2</sup></italic> allele i.e. to label through photoactivation plasma cells in a specific tissue and investigate their migratory patterns.</p><p>We comment on this strategy in the Discussion section of the manuscript: last paragraph.</p><disp-quote content-type="editor-comment"><p>6) As an extension to the above point, were RFP<sup>+</sup> cells scored in other PC survival niches?</p></disp-quote><p>We have not determined the dynamics of RFP labelled plasma cells in other tissues besides spleen and bone marrow. However, we agree with the reviewers on the relevance of investigating other potential plasma cell niches, including gut and associated lymphoid tissues.</p></body></sub-article></article>